Podcasts about Speakers bureau

September 11, 2001, changed Bob Ellis's life, just as it changed mine. Bob was working at the Pentagon that morning and had walked out of the building only minutes before Flight 77 struck the area where his meeting had taken place. You will hear how he immediately became part of the response, helping organize emergency supplies and support for those working at the Pentagon. We also compare our experiences from two different locations that day, Bob at the Pentagon and me at the World Trade Center with my guide dog Roselle. Twenty-five years later, our conversation is about more than remembering 9/11. It is about leadership, teamwork, service, controlling fear, and deciding what we do with the life we have been given. I believe Bob's story offers lessons we can all use when the unexpected happens. Highlights: 05:29-Bob shares how his early life and military support career shaped his path. 23:53-He recalls realizing the first World Trade Center strike was not an accident. 32:59-Bob describes being just 300 yards away when the Pentagon was hit. 37:00-He explains how he helped organize emergency relief supplies within hours. 1:03:54-Michael reflects on survival, fear, and the responsibility to move forward. 1:06:55-Bob shares the lasting life lessons he took from September 11. About the Guest: Bob Ellis is the Vice President, American Logistics Association responsible for Exchange, MWR, Food Service Operations. The native of Fort Walton Beach, Florida began his career with AAFES in 1972. From 1972 through 1984, he held retail management positions as a Branch Manager, and Operations Manager Main Store. In 1985, Ellis began a string of assignments as an Exchange General Manager trainee at Fort Belvoir, VA, and Exchange General Manager, Fort Hamilton, NY and Carlisle Barrack PA, (Army War College). Assignments as Area Retail Manager and General Manager at the former Japan Area Exchange ran from 1989-1992. In 1992, Ellis was transferred to Travis AFB in California as Retail Manager, Main Store. In 1994, Ellis was selected for the General Manager's position at Travis and spent three years assisting in the design and new construction effort of the largest retail Main Store ever constructed by AAFES. From 1997 to 2002, Ellis held the position of Director of AAFES' Washington Office, serving as the principal representative of the Commander, AAFES to the Office of the Secretary of Defense, the Departments of the Army and the Air Force, Congressional offices and industry representatives. Notable among his accomplishments, Ellis was instrumental in spearheading AAFES support to the Pentagon after the attacks of September 11th. Within 48 hours of the event, AAFES established a mobile exchange in the shadow of the impact site to support rescue workers and investigators with critical need and personal comfort items. After Washington, Ellis moved to AAFES Headquarters' in Dallas to assume the Vice President Specialty and Consumables position. In this role, Ellis was responsible for the SD-C Category Team Managers/Buyers. In August 2003, Ellis took his a position as Vice President of Corporate Planning and Communications where he managed the development of AAFES long range and contingency planning programs, oversight of corporate public affairs and ensured compliance with Department of Defense policy guidance with the goal of preserving and protecting the exchange benefit for soldiers and airmen and their families around the globe. Bob joined the ALA on 31 July 2006 where he continues to serve a role in military resale supporting Exchange, MWR, and Food Service, operations still serving military resale over 51 years continuous service. Ways to connect with Bob**:** You can find more benefits how Branded Riches can help you build your Brand, Product, Business, and Yourself at https://www.BrandedRiches.com   Connect:  https://www.linkedin.com/in/neryk-davydov Branded Riches Audiobook by Neryk Davydov https://www.audible.com/pd/Branded-Riches-Audiobook/B0GCP9MMRB Branded Riches Book https://www.amazon.com/Branded-Riches-Increase-Income-Irresistible/dp/1987753836 $5 Free Gift for Creating A New Ovato Wallet    www.ovatoCoin.com  About the Host: Michael Hingson is a New York Times best-selling author, international lecturer, and Chief Vision Officer for accessiBe. Michael, blind since birth, survived the 9/11 attacks with the help of his guide dog Roselle. This story is the subject of his best-selling book, Thunder Dog. Michael gives over 100 presentations around the world each year speaking to influential groups such as Exxon Mobile, AT&T, Federal Express, Scripps College, Rutgers University, Children's Hospital, and the American Red Cross just to name a few. He is Ambassador for the National Braille Literacy Campaign for the National Federation of the Blind and also serves as Ambassador for the American Humane Association's 2012 Hero Dog Awards. https://michaelhingson.com https://www.facebook.com/michael.hingson.author.speaker/ https://twitter.com/mhingson https://www.youtube.com/user/mhingson https://www.linkedin.com/in/michaelhingson/ Thanks for listening! Thanks so much for listening to our podcast! If you enjoyed this episode and think that others could benefit from listening, please share it using the social media buttons on this page. Do you have some feedback or questions about this episode? Leave a comment in the section below! Subscribe to the podcast If you would like to get automatic updates of new podcast episodes, you can subscribe to the podcast on Apple Podcasts or Stitcher. You can subscribe in your favorite podcast app. You can also support our podcast through our tip jar https://tips.pinecast.com/jar/unstoppable-mindset . Leave us an Apple Podcasts review Ratings and reviews from our listeners are extremely valuable to us and greatly appreciated. They help our podcast rank higher on Apple Podcasts, which exposes our show to more awesome listeners like you. If you have a minute, please leave an honest review on Apple Podcasts. Transcription Notes: Michael Hingson  00:00 Everyone, I am Michael Hingson, the host of Unstoppable Mindset. You've heard my voice for the last 471 episodes, but I'm calling you all out today and asking you to listen to this because we're going to make a special announcement now regarding the next four episodes, starting with 472. We're going to help commemorate the historic events of September 11, 2001. Yes, they're definitely historic, although not necessarily the most positive things that have ever happened. But as many of you may know, I was in the World Trade Center working on September 11, 2001, on the 78th floor of Tower One, and escaped with my guide dog. I've delivered a speech about that, which we put in the first episode of this podcast series back in August of 2021. But this Friday, episode 472 is going to have an updated speech that I delivered just a few years ago at the Marshfield, Missouri Cherry Blossom Festival. That festival is a yearly event celebrating different kinds of things that have happened in American history, and I was invited to come and speak, which I did. I'm going to put that speech up for you as episode 472. I think you'll find it enlightening. It'll teach you something about blindness and blind people. It'll tell you my story, and it'll give you some inspiration that I hope you will find helpful. Next Tuesday, september 8, Michelle Abraham is going to interview me. Michelle is with Amplify You, the company that does all of our back office stuff and helps me with the editing and other things regarding the podcast. Michelle owns her own podcast, and she is going to interview me about September 11th and other kinds of things relating to what I've learned and things that have happened over the past 25 years. She's also going to be putting this up on her podcast Amplify You, so you can find us in a lot of different places. On September 11th, I'm going to chat with Bob Ellis. Bob was in the Pentagon on September 11, 2001, and had literally just walked out the door of the Pentagon when the plane crashed into the Pentagon and did the things and the damage that it did, and of course generated all the things that occurred at the Pentagon. On the 15th of September, I'm going to come back and have a conversation with all of you about lessons that I've learned over the past 25 years, and just reminisce a little bit about all of that. While the podcast is occurring on September 11th, I will be actually in Kilgore, Texas, doing a speech about September 11th. So lots of things going on, I hope you listen to these episodes. I hope that you'll tell everyone that you can about them. I really enjoy all of the support that you've given us over the years, and we're going to continue to do things with Unstoppable Mindset. And of course, as always, if you'd like to come on or know anyone who would, please let us know. We're always looking for guests. Thanks very much. We'll see you on Friday with the first of these four episodes. What if the biggest thing holding you back isn't what's in front of you, but rather what you believe? Welcome to Unstoppable Mindset, where inclusion, diversity, and the unexpected meet. I'm your host, Michael Hingston, speaker, author, and advocate for inclusion and possibilities. This podcast explores how the beliefs we carry shape the way we live, lead, and connect with others. Each week, I talk with people who challenge assumptions, face adversity head-on, and show what's possible when we choose curiosity over fear. Together, we focus on mindset, resilience, and the small shifts that lead to meaningful change. Let's get started. Hi everyone, and welcome to another episode of Unstoppable Mindset. You are listening to us today, or at least I'm assuming you're listening just when this came out. But whenever you're listening, it is today, September 11th, 2026, which is needless to say, a special day. If you have kept up with my podcast from the beginning, you know that I worked in the World Trade Center on September 11th, and ever since then I've been a public speaker, traveling the world, talking about trust, teamwork, leadership, the human-animal bond, and a variety of things. But recently, I met Bob Ellis. Michael Hingson  04:40 Now, Bob, as it turns out, on September 11th worked at the Pentagon, and I have not ever really had the opportunity to talk with someone who was at the Pentagon, especially on September 11th. But we get to chat about that today, and Bob knows our rules, which are basically. He sent me a series of questions that he wants to cover, but we are doing this as a conversation, so we'll probably talk about a lot of the things that he specifically sent. But we can go any old way that Bob wants to go, so that's what we'll we'll make this really fun. And I'm really looking forward to having the opportunity to talk with Bob. So again, welcome to September 11th, and Bob, I want to welcome you to Unstoppable Mindset. We're really glad you're here, Bob Ellis  05:28 Michael. Thank you for inviting me. I know you you've inquired several times, and I've debated it, and and I was just holding it for the right time, and this is the right time-the 25th anniversary of the event. Michael Hingson  05:40 Yeah, it is, and and and as as we've said, if you find anybody who needs a a speaker to come in and speak, let me know. But but for now, we get to chat about you and and hear your story, which I think is the important thing. I think we'll probably talk about both of our stories in the course of the day, no doubt about it. But I really am glad that you are here and that you are able to to talk with us today and and and talk about things. So let's start the way I love to start with people. Let's start at the beginning. Tell me kind of about the early Bob growing up and so on. Let's start with that. Bob Ellis  06:17 Well, I I grew up in let's say grew up until I was four years old. I lived. I was born in Pensacola, Florida. Lived in the Panhandle. Mother and father got divorced, and we moved to Norfolk, Virginia. And it was just my my mother and I until I was 14 years old. And I found out about my dad and found some letters from him and insisted to go see him. And so, between 14 and 15, I made a couple of unauthorized attempts to to make my way to Florida. On the third attempt, I made it, and it was quite a surprise for my father. Ended up living with him and being my closest friend up until I had he had grandkids, we had kids, and so I lived and grew up in the Destin, Fort Worth, Fort Walton area. Went to work, and this is where the story begins. I went to work at Eglin Air Force Base as a as a janitor in a gas station for the Army Air Force Exchange Service, so that I could continue to play high school football and practice, was a great job. It was an opportunity to work with the military, be around the military, and I took great pride in that feeling that that that that while I I wanted to go into the air force and I wanted to fly jets, that opportunity just never presented itself because the Vietnam War was going on and they were banking pilots instead of taking pilots. Anyway, I I ended up staying with the Army Air Force Exchange Service for 34 years. I moved all over the world. I've seen the every AOR and every combat scenario since the Vietnam War. Not in the Vietnam War, but I was in the refugee program, helping with the resettlement back in 1972, 1973. Spent the rest of my career going wherever they sent me, and and and that was from Tokyo, Japan, to to Tuli, Greenland, to California, and ultimately to to Texas. Michael Hingson  08:30 I remember during the Vietnam War, someone called me one day. I was a student at UC Irvine, and there was a refugee camp fairly close to the university, and someone said, and someone said, "There's a blind young man at the sent at the refugee center, and we should go see him. And so we we bought a transistor radio for him and went out to visit with him and spent some time with him, and I never got to see him after that. But I hope I hope he did well. He he seemed like he was doing okay, but he was a little bit lost, needless to say, because it's a whole bunch of people. There are no a lot of people who knew much about blindness and blind people, but I would presume he did reasonably okay. I hope so, but that was the only time I specifically had an involvement with him or anyone at the refugee camps. Later, when I met my wife Karen, she lived, I think, a door down, and she and her parents lived a door down from a Vietnamese couple, and he was a tailor and actually made her wedding dress, which was kind of cool, and so we got to spend a fair amount of time with the Voo's, which was was good, but what's. Interesting for me now, with with now being well so many years later. In November, I will be going to do a speech in Hanoi, so I'm really looking forward to to going over there and and experiencing it. At least it'll be a little bit cooler then than it probably is now. So we'll see, but it'll be it'll be pretty enjoyable to go and again see a different a different part of the world, and I I think we'll be fine. At least that's that's that's the plan. Bob Ellis  10:34 That that that that tour that I had at Eglin Air Force Base with the refugees, will come back to to to 911 2001 and the experiences that I had at that refugee camp replicated in the Pentagon park and lot there in 911. So we'll get to that. I'll explain it further. Michael Hingson  10:56 Yeah, I'm sure it was a a great a great lesson. Where did you do college, or did you Bob Ellis  11:03 went to went to Duke University and the University and the University of Maryland? Michael Hingson  11:10 Okay. Well, at Bob Ellis  11:12 least much of it was correspondence as well, only because I was deployed for for so many years back to back, 17 moves in 34 years. Michael Hingson  11:22 Wow, Duke University. At least you didn't go to one of those other schools in North Carolina. Boy, talk about talk about rivalries and basketball. What a what a group down there. Bob Ellis  11:35 Oh, I know, I know. Michael Hingson  11:38 I once spoke in Kentucky, and the Wildcats were in the NCAA championship that year, and I was asked to speak at an event on the night of the championship. But I was told I had to end by 630. I could not go one second past 630 because the gym I was speaking in was going to clear out. Well, I ended in time so that at 630, what they said was absolutely true. That gym cleared out. Everybody went home to watch the game. Bob Ellis  12:09 That's that's sports. Michael Hingson  12:11 Not sports. It is, but it's okay. I I learned a lot down there and got to meet a number of people, and so it was it was a lot of fun to to do it, and then years later I was in North Carolina when NC State and UNC were playing to see who was going to go into the championship. So again, pretty interesting world, and and sports ruled everything then, so it's okay. It Bob Ellis  12:43 hasn't it hasn't changed at all because my my my daughter I got her graduate studies done at NC State, and it hasn't changed a bit. It's just I'll bet it's just crazy as it's when was 20 3040 years ago, Michael Hingson  12:58 and it shall ever be, won't it? Bob Ellis  13:01 Yeah, yeah. Her undergraduate degree was at University of Texas. This was my son's, and she went on to NC State, and and he went on to medical school in in Houston. Michael Hingson  13:16 Okay. Well, UC Irvine, when I was there, had the championship water polo team, but that's what we had. But they started basketball while I was there, although it wasn't anything huge. But a couple of years ago, they made it to the Sweet 16, and that was kind of fun for UC Irvine. One of these days, it'll go all the way. Bob Ellis  13:40 Yep. Michael Hingson  13:41 Well, anyway, so you you went to college, and and what did you major in? Bob Ellis  13:45 Political science. Michael Hingson  13:47 Okay, political science Bob Ellis  13:48 and business management. With a with my two aspirations, I wanted to. I really wanted to major in in aviation science, but that that wasn't offered. So that's political science and business science, business law. Michael Hingson  14:06 But you were working for the Army Air Force Exchange Service. What is that exactly? Bob Ellis  14:11 Yeah, it's a it's it's it's a non-appropriated funded Service provided all goods. I think of it as the the Walmart or the Target of of the civilian sector, except the Army Air Force Exchange Service has stored everything from stores, every business that you can think of therein, from stores to convenience stores to gas stations to beauty shops and barber shops to dining facilities, franchise Burger Kings, anything that a soldier and his family needs at the base or overseas or in the combat arena, where we were there with it, providing it. It's been a great career. Michael Hingson  14:59 Did you? Do you have any involvement with, especially here in the U.S. the the Randolph Sheppard programs, the blind vending stand operations at any of the facilities? Bob Ellis  15:09 Yep, sure did many many times. We're still working with it. There's there's some issues present right now under the Randolph Shepherd that they're looking at. I don't know what what's going to change, but yes, sir, we were very, very close to that. Michael Hingson  15:24 Yeah, I know there. The current government's looking at it; they want to scale a lot of it back, which would, I think, not be a good thing. I think there's a lot of reasons to keep it, but we'll see. We'll see. We'll see how it goes. But I, the closest I ever came to dealing with anything from AAES was I was invited to speak once at an organizational meeting of the National Property Managers Association in the military. Are you familiar with that? Bob Ellis  15:56 I am. Yes. Michael Hingson  15:57 And when I was asked to come, the Speakers Bureau didn't do a good research job because they told me, "Oh, it's the people who rent apartments and all that. When I got down to the to the event, I will say that the National Property Managers Association certainly serves a nice breakfast. But anyway, the conversation just didn't seem like what I what I was expecting. So I asked somebody, and they told me that the organization was the organization that had complete jurisdiction over anything physical that the government owned, and Bob Ellis  16:30 absolutely Michael Hingson  16:31 that that changed my grass. Sorry, Bob Ellis  16:34 right down to the grass, right down to the grass and the concrete. Michael Hingson  16:37 There you go. Well, it also changed my speech in 10 minutes, but it was fun. They invited me back the next year, so that was good. But it's it's fun when you're you're planning to do a particular speech, and suddenly it turns out it's got to change. It's good to have the flexibility to do that. But I'm I'm glad I had the opportunity to do it, and hopefully we'll have opportunities to do it again, but you have served a lot of different kinds of of services within AAES, and and I assume that's all worked out pretty well. Bob Ellis  17:14 That that worked out very well. Yep, I had I started at the bottom and and climbed as close to the top as I possibly could, but Michael Hingson  17:23 you eventually got the the highest medal that was available for civilians when you retired or after you retired. Bob Ellis  17:31 No, the highest award that I ever received was from my man over the Pentagon 911 support program, which was a nice medoris civilian award. Michael Hingson  17:46 Okay, where is your favorite place to live in the world? Or is that really easy to say? I mean, you've been all over the place and seen a lot of different kinds of places. Don't know how much you got to two of them, but anyway, Bob Ellis  18:00 it wasn't the two places that I that I went overseas, which was Japan and Greenland. Those were the longest tours of my life. Beautiful country in Japan, and and great facilities and support in tuning Greenland. But I would I would guess throughout the United States, I had a great assignment at the Army War College, and I had a great assignment at Travis Air Force Base here in Michael Hingson  18:26 California. Yeah, Bob Ellis  18:28 yeah. Michael Hingson  18:30 I've spoken. Bob Ellis  18:30 My son was born in Japan. He's dual citizen as a result on the Air Force Base, and my daughter was born in California. So it was a great time, mainly because the kids were younger and and and and we were in great climate areas. Michael Hingson  18:48 When people ask me what my favorite place in the United States is, I say everywhere. I I just enjoy meeting people wherever I go in the U.S. It's so many different cultures and customs and ways of doing things. It is so fun to to see all the different places and see how they are. People ask what I like, where I like outside the U.S. And so far, it's been New Zealand. I would say is probably the best, but Japan has to be up there too. I've really enjoyed being in Japan. I've been there a couple times, and I thoroughly enjoyed Bob Ellis  19:23 it. I, I had, I think the most the the greatest thing about the assignments was some of the people I I got to to meet in in my in my tours. One of them would be the Crown Prince of of Thailand, who who is now the king of Thailand, King Rama, got to meet him when he was a pilot, and supported him when when I was at Yokota Air Base, and multiple other celebrities. I I had the opportunity as a kid to attend the funeral. For Douglas MacArthur, and and his his memorial was right across the street in North Virginia from where my mother worked. And 20 years later, I had the opportunity to to meet mrs. Mcarthur, Jean MacArthur, at Gracie Mansion in New York, and I I I wrote protocol. I when it came time for her to to meet me and meet meet her, I got down on one knee and I held her hand and I said, "I want to tell you a little story, ma'am. And she said, "Well, certainly, absolutely. And I told her the story how when the general had died in in 1964, I was required by my my mother to go to the funeral, and the most fascinating person I'd ever seen in my life was herself, and she just got she just turned red. Well, long story short, I was at an army command at Fort Hamilton. The next day, the the group the the installation commander called me over to his office, very angry, but he wanted me to know that I was going to be the first civilian aide for the old lady, which was mrs. Mcarthur, and he had to take one of his lieutenants off. And I got to know the family and and the Mcarthurs as a result of that. So lots of opportunities, just absolutely amazing. 911, and we'll get to it. I got to meet President Bush momentarily, but I I got to meet him and have a short conversation. Michael Hingson  21:32 I got to meet him in 2005. We went to the Oval Office, and we were supposed to have a two minute photo op, but he kept wanting to interact. We ended up talking for about 15 minutes. He kept the Italian ambassador or prime minister waiting, but it was a was a great conversation. I very much enjoyed having the opportunity to meet with him. Bob Ellis  21:53 Yeah, he was remarkable. Michael Hingson  21:54 Yeah, in in so many ways. If Speaker 1  22:00 you enjoy Unstoppable Mindset and would like to help us continue bringing these conversations to you each week, we've created a way for you to support the show. Your contribution helps us cover production costs and continue sharing stories, insights, and ideas that inspire people to live with purpose and possibility. If supporting the podcast feels right for you, you'll find the link in the show notes. Thank you for being part of the Unstoppable Mindset Community. Michael Hingson  22:33 So that's that's pretty cool. So as you were going around to all these different places, what would you say you were learning. Bob Ellis  22:41 I was learning business. I was learning relationships. I was learning marketing. Pretty much anything that you wanted to do as a general manager or a vice president, the exchanges let you do it. You know, until you got too far gone, and they they reel you back in. But I love being able to run multiple businesses on the installation, and and be accountable for them, and run them at a profit, and and at the end of the day, do great things for military families. Michael Hingson  23:16 Wow! So you um, you you've you've had a lot of challenges and and had to learn a lot of different things. Needless to say, but I would would think that you've you've been able to to keep a lot of that and use it. And you know we've referred to September 11 th, and so let's let's get to around that time. The first thing I would ask, and people have asked me, but you're in a better position in theory than I. Did you have any inkling that something like September 11th was going to happen? Bob Ellis  23:53 Well, actually, September 11th was was happening. I left for work about 4:30 in the morning. I lived out in the suburbs in Centerville, Virginia, and it was one of those days that you just wished you didn't have to go to work. It was the as the sun was coming up, it had a little cold breeze to it. The skies were blue. It was just one of those days that you just wanted to sit out in the yard and and relax or go bicycling, whatever. But I did my duty and I drove in to the Washington D.C. area and reported to my office on time, which was right around 5o'clock. My staff showed up around six and some at seven, and my secretary came in, and I don't know exactly what time it was, but it was shortly after, right around 9o'clock in Eastern Time, when the first airplane had hit the the trade center. Michael Hingson  24:49 Yeah, Bob Ellis  24:49 846-940-6846, Yes, right, 846. Yeah, and and so I I went in to look at the. The the television monitor standing there it was just her and I at the time and and and I said that's not an accident and she says how do you know that I said look at the skies that was an airliner they were talking about it was a little small private aviation well I'm a pilot I've been a pilot for 40 years 41 years I knew exactly, you know, that that where it was, what it was doing, and that wasn't a it wasn't an accident. And and my inkling was is that I was in a in rented space in Arlington, Virginia, because we had been moved out because the wedge that got attacked was the one that was still under construction. My office had not been completed there, and and I had a meeting in that wedge at 9o'clock that morning. And my secretary said to me, "You know, Bob, the Pentagon is next. And I paused for a minute and I looked at her and I said, "How in the world could you even imagine that, you know that that that's a fortress? Who would be crazy enough to attack the Pentagon? And she says, I I just I don't want you to go over, you know, just just just do it by phone, which I I probably could have done. And I said, No, I'm I'm going to go over there. If they're going if they're going to attack the Pentagon, I'm going to go down with it, and that was kind of my philosophy. So, in the back of my mind, seeing that airplane hit the Trade Center and her telling me that certainly made me wonder if it wasn't a possibility. Michael Hingson  26:33 So, you didn't. You don't think that anyone, and I've never heard of any such, but that anyone had any advance notice? There wasn't chatter. There wasn't anything that made people suspect what might be getting ready to happen. Bob Ellis  26:47 No, I I I think that is the the worst our country has ever been off guard. It reminds me of you know the the attack on Hawaii and that you know in in Pearl Harbor. We were completely unprepared, and I thought we were completely unprepared on 911. And in fact, after the attack, I knew we were unprepared when I saw the two jets fly over with no armament on the wings. So no, I don't think anybody had any idea. Michael Hingson  27:18 Well, the other side of it, and I've talked about this in in some talks I've given. I talk a lot about trust and teamwork, and like it or not, one of the things that I observe is you had 19 terrorists who functioned well enough as a team that they didn't talk about it. They didn't let anything come out. So no matter how much armament or whatever we might have had, I'm not sure whether we could have predicted that on September 11th, what occurred was going to happen. Bob Ellis  27:49 You know, all the indicators were there. You know, those those 19 trained at private airports, and they and during their training, it was it was reported multiple times that all they were interested in was taking off, not landing. I mean, first clue, you know. Okay. Why would you just be interested? He's taking off an airplane, and and I always found that very curious, and I'd heard it several times. That should have set alarm bells off. Should have. It didn't. Apparently, it did. Michael Hingson  28:20 Good point, and you know the the thing is though that, as as you pointed out, who would have thought that anybody would attack the Pentagon, the fortress that it was? Who Bob Ellis  28:33 yeah, Michael Hingson  28:33 who would have thought? So again, you can only go by what you got, and so nobody, I think, would have ever imagined that. Well, of course, the first plane hit the World Trade Center, and at first, people didn't really know what happened because there were really not very many people who who saw it. In fact, we only have the few photos that were taken by the French photographers who were there for something else, but then a little after nine, the second plane hit, and that changed the dynamic and changed the perspective a lot. Although a bunch of people who started seeing it on TV thought it was just a movie, and it wasn't true, but the second plane hitting changed the attitudes. I think for most people, and that's when people knew something was going on. Bob Ellis  29:24 Yeah, I didn't know anything about the second trade center. I had left my office in Crystal City, and I had headed to the Pentagon. And the meeting, the meeting that I had was with the Army Personnel Chief and several other folks. And as it turned out, that is exactly the window that the airplane flew into. That was ground zero for the for the for the target for the airplane going in just above the first floor for the Pentagon. So I didn't know anything. I was I was trapped at that point. I was trapped. Couldn't go um. Wouldn't go um. Didn't want to go um. And I had lived in New York City for five years, and I was my biggest. I was always impressed by the New York City Fire Department. I mean, they're they're just walking heroes if you've ever seen them. I mean, they were like they were like giants when you got next to them, and that they would they were just superhumans. And I always wondered upon the top floors how in the world you would get a fire put out at the top of the World Trade Center, and and I did not know until two days later when I made it home. That was my first question to my family: How did they get the the fire out at the top of the World Trade Center? And I and and it was repeated to me centers, and I said, What are you talking about? Centers in my family, and they said, "Bob, the World Trade Centers are gone. I said, "I don't understand. How could they be gone? And that was that. That was you know two days later that I found out about that. It was quite a shock to me to learn what it actually while I was on on the Pentagon mission. Michael Hingson  30:58 Well, when the first plane hit. Well, in the second plane, the firefighters were going up the stairs carrying all their equipment, and I had had had known about that and asked people, "Well, why are you or would you be carrying equipment? Because I met I I didn't meet the FDNY people ahead of the World Trade Center attacks, but I did meet with other people to learn about emergency preparedness and so on because I felt as the leader of an office, it was my job to know because I wasn't going to be able to read signs, and I love information, so I was trying to learn all I could, and they told me that where would if you if you had equipment stored in the in the towers, then people would go to it. Firefighters would go to it and get the the equipment. What floor do you put it on? Because no matter what floor you put it on, what if the fire broke out one floor below? You know, you can't get to the equipment. So the only way they could get up the stairs to fight the fires was to carry all of the equipment with them, yep, yep. Not enough is said about those guys in history. No, and I met a number of them coming up the stairs as we were going down, and they wanted to escort me down, and I didn't want them to do that because I knew they were a team, and I I pushed back pretty hard and said, no, you guys go up and we'll go down unless we can help you fight the fires, and they said no. The reason they eventually let me go down without any assistance was I had a friend with me who could see, and I said, "Look, David can see. Don't worry about us. And David and they turned to David and they said, "You're with him. And David said, "Yeah, leave him alone. He's fine. So we went on down, and they went up. I don't know whether the people we interacted with made it down or perished up above. It was about 10 after 10 after nine or so when we got to the 30th floor where we met them. So it was another hour and almost 20 minutes before the tower collapsed, but I don't know where the firefighters were, or how many people from the groups that we interacted with perished, or if they all made it out. I don't know, but Bob Ellis  33:12 yep, I I memorized all those numbers. You know, 189 between the airplane and the Pentagon, 200 injured, but 189. 189 total were 64 on the airplane, 125 in the Pentagon, and I'll never forget those numbers. Yeah, I'll never forget the time. I looked at my watch at 9:17, and and I have to tell you that on 9/11, I always sit very quietly until I get past 917, not 937. I'm sorry, 937. Michael Hingson  33:48 So Bob Ellis  33:48 in the morning. Michael Hingson  33:49 So, how close were you to where the plane came into the Pentagon? Bob Ellis  33:56 About 300 yards. When when it was clear that the meeting wasn't going to happen because the air traffic control system had been shut down. They released us to go back to our our offices, and I was going out the front door. I left about 930. It was supposed to start at nine 930. The generals said we'll just reconvene, and and I agreed. And from his office on on the south portico, I was walking out the front door. Literally, I heard the engines spool up. I had been in the AOR in rail combat munitions, and and I've heard cruise missiles, and and I could hear this one spinning up, and I thought it was a cruise missile, and so when it hit when it hit the building, it was just it was just a horrendous sound. But my first impression was to run to it to see what happened, what what what caused that, and there was nothing there. It was just four or five cars burning and smoke billowing out of the building. And and the the rest turned into a you know a rescue and a a recovery. Michael Hingson  35:08 AOR is what Bob Ellis  35:10 the area of responsibility. Michael Hingson  35:13 Okay, area of responsibility. Okay, Bob Ellis  35:16 yeah, Kuwait, Saudi Arabia, wherever we are, it's it's N A O R, and that's your A O R. That's state. That's where you are. So that that's where I encountered first first and only live person coming out of the building, and which was a which was a really big surprise. But I knew that there was something that I I had to do, and and one of the things was to, if he needed assistance, getting him assistance. And there were several people. He was he was he was burned third degree burns over his whole body. He lived. I said one prayer was for him. And as it turned out, he became a a great ambassador. Turned out to be a great friend, and is actually back in the Pentagon to this day, just steps away from his old office as a civilian, went went back on a presidential appointment. Michael Hingson  36:09 So, you mentioned the general a while ago. Was did he survive? Bob Ellis  36:15 No, he was the he was the highest ranking person that we lost in in the entire encounter, and it was the entire office was just instantly vaporized. So he did not survive. Michael Hingson  36:33 Well, so you heard the engines revving up, and you went after you heard the explosion and so on. You went over to see what was going on, and then what did you do? Because it certainly had to be a major surprise and a shock by any standard. Bob Ellis  36:49 Yeah, I went that side of the building, saw the hole in the building, kind of convinced myself it was a cruise missile, but I never heard such a loud engine noise. As it turned out, it was it was two big engines off of a 757 200, and so I immediately tried to figure out you know what can I do? What should I do? Should I even be here? And that's when I saw the colonel coming out of the building, and I was able to walk with him and four others over to the the road, the Washington Boulevard that goes around the Pentagon, and and I sat down on the telephone pole, a light pole that the airplane hit going in. Now I'm a pilot, and and I have to tell you to take an airplane going at Mach point eight seven, and hit a target, hit the building, and not hitting the ground was just absolutely amazing to me. So as they got the colonel into an SUV and and and got him out of the the scene, I sat there. Just it was almost like a movie I was watching. The triage was being set up. The Pentagon was burning. The emergency services units were starting to show up, and we had very intermittent phone capability. And I had I had a a friend, my my the commander that I worked for in Dallas at the time. This secretary's husband was a bodyguard for Secretary Rumsfeld, and and Secretary Rumsfeld was actually carrying litter patients, carrying people out of the debris area and out of the offices. He was actually helping people, and he he realized that something needed to be done. So he gave Jerry a note, a piece of paper. We called them snowflakes, but it was a tablet, and he had listed what needed to be done and what needed to be done now. And Jerry found me sitting over there and gave me that that piece of paper, and it had everything listed on it. He wanted a a tactical field operation in place. He wanted it now, not yesterday. He wanted something in the interim, and it was to provide emergency relief supplies. So I I sat down on that telephone pole and I called our our local dist not local our largest distribution center in the world was down in Newport News, and I got the director on the phone and I said, I have an official order from you coming from the Secretary of Defense, and and don't override, don't just just follow my instructions until we can get to the commander at AFIS headquarters, and so I gave him the list. I just gave him the full list of things that we needed to get rolling, and I called another gentleman that was just across the river, the American Logistics Association, which owned all of the brokers and manufacturers, and I gave him a list of stuff that we needed now, like Gatorade boots. the The surface was over 2000 degrees, and the emergency service boots were melting almost upon contact. So I had I had 1000s, hundreds of 1000s of dollars of equipment. And supplies coming in, and we set up the USO tent, put everything in the USO tent. We raided all the stores in the in the Washington D.C. area. I was able to contact the region manager, and I told him, you know, what we needed to take it off the shelf, put it in the back seat of the cars, don't account for it, and get it to me. And that's what we did the entire first night was setting up the USO trailer, and the next morning I had two tactical field tractor trailers coming up the ramp just as the sun was coming up, and they were loaded with supplies, and that's what stayed in place for the next two months. Over $2 million worth of merchandise, emergency recovery type merchandise, everything from linens to the towels to eye wash, and and and we had to actually have some special boots made out of leather for the dogs because the dogs' feet were so it was it was quite an operation. We ended up well running within within 24 hours of the attack, Michael Hingson  41:04 why is it that you are able to stay pretty focused through all of this? Bob Ellis  41:08 I you know I you know I I've often asked that question. I wanted to go home. Alls I could think of is my kids, my wife. What what are they doing? What are they thinking? They're watching this on the news, and I had I had drifted over to which my car was very close, and it was taped off. The parking lot was taped off. It was a crime scene. There was no going anywhere. There was no transportation. If I wanted to walk 40 miles, I guess I could have, but because I couldn't go anywhere, I had to do something there on the scene, so that's that's that's what I did, and and it wasn't until the next day when the phone started working again, our two star in Dallas was able to get through to me on on my BlackBerry, and he wanted to know what the situation was, and and and I told him, and and he said, what what are we going to do? And I explained to him what we had done already, and he says, "How did you do all of that? I said, "I picked up the phone and I told him I was working for Secretary Rumsfeld, and this is the order. And and he says, "How are we going to pay for all of this? I said, "Sir, this is our finest hour. We're not. We're going to donate. These are all donating goods, and and it really was an interesting. I I just I just don't know. I was compelled. He he he ordered me on that second day to go home, and and I said I had no way to go home. And he said go to the motor pool. I'm going to call the motor pool. He had been the commander of the Air Force One Squadron, so he had a lot of connections in Washington, and he he got me a car, and I went home long enough to change clothes and and and to come back out. So it was it was just out of adrenaline, I think. Somebody had to do something, and and everything that I've told you here today is not written anywhere in history. I own every bit of what happened in in in that story, other than some of the people that were working there. Michael Hingson  43:07 What phone did you use that first day? You said you're you're it was the second day or the next day that you're phoned. So how were you able to communicate? Bob Ellis  43:17 We had Blackberries, and and until the networks got completely overrun, we were able to use it. And and so by the second third day, we we had pretty consistent communication, because the the the commander called me back that same morning, and and he said, you know, he said, how come you haven't been home? And I explained to him, and he says, "Will you do me one favor? And I said, "I would. He said, "Will you go back into the building? Said, "Sir, the building's on fire. He says, "Well, well, you get in the front, and I'm looking at it. He was looking at it on television, and the military clothing store was in the very front, within 100 feet, probably of that door that I went out of. And he says, "Would you see if our people survive, and if the store itself survived? It was sitting near the the area. I went in the store. I went into the building, into the burning building, and was able to look in the door, and I could see that the the room was full of smoke, and the door was locked. So I told him I would assume that our people made it out, alive and okay. And they say that was a, and they did, and they absolutely did. And in fact, everybody that that that that had any kind of supervisory capability around the Beltway, they volunteered to come over and work for me and and operating that facility for 2024 hours a day, seven days a week. Wow! So and not and not to shorten the the question, I wasn't there, but because of what I was doing in the in the Pentagon, my old homestead was at Fort Hamilton. Fort Hamilton picked up the same thing and went over to the Trade Center area, and they gave them a place to put a mobile. Food truck, and they brought supplies in and pretty much supported the firefighters and the and the and the police there. So so we had quite an operation going for a long time. Michael Hingson  45:11 Yeah, and and needed to, but it was interesting and commendable that in both places people were able to focus, and were able to carry out missions. I know at the World Trade Center when the two towers collapsed. Of course, it was it was unexpected, but we know now, of course, why they collapsed. It wasn't that the planes hit; it's that they were they were full of what 36,000 pounds of jet fuel each, and that exploding jet fuel is what damaged the infrastructure of the buildings to cause them to be able to collapse. But as well as at the Pentagon, but very quickly people were able to start to move and deal with issues and put procedures in place that were able to, I'm sure, keep more people from perishing and keep kept more people being able to focus throughout the whole the whole sequence of events. It it certainly was very scary, but it is something that that people like you were able to do. I know for me, the reason I was able to focus was because I had learned what to do in an emergency at the World Trade Center. I spent time with people and I learned how the whole building was structured, so I knew when the building tipped, why it tipped, and and things like that. You Bob Ellis  46:40 felt it. You you felt it. Michael Hingson  46:43 Oh yeah. Oh my god. We moved probably at least 20 feet, and then it came back, and oh my Speaker 2  46:48 god, it Michael Hingson  46:48 got vertical again. It got vertical again, and then a few seconds later, it dropped about six feet because the expansion joints went back to their normal configuration. But Bob Ellis  46:59 we uh we we knew from 937 till about 5o'clock that evening there would be no more survivors. It was over, and and and the dogs were getting depressed because they were they were they were not cadaver dogs. They were recovery dogs, and they were used to fight. And we we actually had ceremonies for the dogs every day, where we sewed flags onto their collars, and they had special water and special food. So they played a big, big role in morale, mine especially. Michael Hingson  47:33 And at the same time, I know people had to do drills to keep the dogs focused because they weren't able to find people, as you said, so they had to do things to give them something to find to keep them happy, which was was so important. Bob Ellis  47:50 Yeah, that we had two two tractor trailers lined up. It was just just two 300 feet from where you went into the damaged area of the Pentagon, and those dogs and their handlers would get up underneath those trailers and sleep, and they would play with the dogs. We actually had some carpets brought out, tarps brought out, and that's kind of where that was kind of their headquarters during 911. We had to make it up as we went along, and and the other interesting part of this story is in 1972 at the at the refugee camp, I was sleeping in the back of a van because there was just no way to go home. It was too it was too far to drive home to turn around and come back at 8o'clock the next morning, and I heard somebody knocking at the door, and and and I and I opened up the door, and it was a military colonel in uniform, and there was a civilian standing there with him. And he says, "Are you part of this operation? And I said, "Yes, sir, I am. He said, "Who are you with? And I said, "The Army Air Force Exchange Service. And and he says, "You're not provided any other facilities. This, I said, that was my choice. And as it turned out, I was speaking to Secretary Rumsfeld during his first administration as Secretary of Defense, and it was interesting that when he found out that what I did in in that program, I won the Indo Indo China Award for service, and then of course you you move ahead to to 2001, and we we knew each other. I had briefed him several times, and we we knew each other in the Pentagon. And that day, he knew that I would know what to do for the support role, and that's why he sent the letter up. And as it turned out, when he retired and and left the Pentagon, he was on a book tour, and and the the general secretary and myself got an invite to come to the book tour with him and and have lunch with him. And he handed me a book and he said, "I want you to have this, but I don't want you to open it up until you, Bob. I don't want you to open it up till you get home. I don't want you to give it to your wife. And and it was like this. Sure, I'm not not a problem, and so I got I got home. You know, this is this is 10 years later, and handed the book to her, and I said, "Open it up. I'm not wasn't allowed, and there's a nice thank you page on the front from Secretary Rums for allowing him to use me on 9/11, and you just you just that's the best reward that I could have ever ever expected. A guy that I just idolized to do that. Michael Hingson  50:26 When you got home, so you weren't able to talk to your wife before you got home, or did you ever get communication so you could call her? Bob Ellis  50:33 No, I didn't. I when I finally got the phone back up and running and got in the car. I had lost the battery, so I said, "I'm gonna be home in in an hour. I'll just be there. But General Wax called up, and she answered the phone. She went. She went sometime during that day and pulled the kids out of the private school, brought them home. She could see my car. It was a yellow SUV, and she could see it in the South parking lot in the news choppers going around. She said that was my car where my spot was, and General Wax got her on the phone and she and and she answered the phone and he said this is C J Wax and she thought that was the call. She thought that was it, and she alls I could do was drop to my knees and and and C J said and it's it's okay. I've ordered him to come home. He's all right. He's running. He's running a a program for us for for recovery. And if he's not there, he should be there shortly. And then by the time I got there, I got to the front step. I'm asking the question about the World Trade Center, how they got the fire out, and I was ordered that I could not go in the house because I smelled like smoke. So, so two minutes before that, I was the most important person in the world, and and then all of a sudden, I was I was back to Bob, and I wasn't going to wear that that suit in the house to to smoke it. So anyway, that's that's how she found out. He he called her up. I asked him. I think I asked him if he would get in touch with her at our last conversation, and he did. Michael Hingson  52:06 Soon after both towers collapsed, like a minute or so later, I called and got through to my wife Karen. I had talked with her before we left our office, and then when we got downstairs, I couldn't get through to her because the circuits were busy, and it was obvious that everyone we learned later was saying goodbye to loved ones, and so the circuits were busy. So after both towers collapsed, I was able to get through to her, and as I tell people, there were tears on both sides of the phone at the when that conversation started, but she was the first one who told us how two aircraft had been crashed into the World Trade Center towers, one to the Pentagon, and at that time, the fourth one was apparently still missing over Pennsylvania, and of course, then it crashed at Shanksville. Bob Ellis  52:52 I love it. Michael Hingson  52:54 Yeah, but we, you know, we talked, so she knew I was okay. Then a friend of ours, Tom Painter, who had been a friend of Karen's at high school out in California, but Tom, over the years, had ended up moving to New Jersey. He came down to stay with her, not knowing until he arrived whether I was in the office that day or out with a customer or what was going on. And of course, then she told him, and so he drove her to the train station to pick me up. When, when I got back out to Westfield, we went home. And you talk about with with dogs. We got in the house, and I took Roselle's harness off because I was going to take her out, and she would have none of it. She ran off, grabbed her favorite tug bone and started playing tug of war with my retired guide dog Linny, and I talked to the veterinarians at Guide Dogs for the Blind in San Rafael the next day, and they said, "Did anything threaten her? And I said, "No, not directly. And they said, "That's why she ran off because it was over. Nothing threatened her. Bob Ellis  53:58 Comfortable. Michael Hingson  53:59 She, they don't. Dogs don't do what if like we do, and so she was comfortable. She was happy. She wanted to play, and then then she did go out. But by the same token, the the whole point was that she was able to deal with with all of it and was able to to focus. Then we got her outside and and came back in, and she ate and and all that. But the the the thing is that she focused all day, and and she did a a wonderful job. And the reason that she focused and did so well was mainly because I worked at keeping her focus by telling her every chance I got. You're a good girl. What a good dog! Good dog. You're doing a great job. Keep going. I did that all the way down the stairs in the World Trade Center, and I was very deliberate about that because I knew she had to sense the fear and what was going on, and I wanted her to know that I was okay and I was going to be there for. Her, which is of course what teamwork and support is all about. You understand that very well. You you proved it in so many ways. I kept working with Roselle and kept her focused, and you know it all it all really went well. I still think one of the most relevant things for me in the World Trade Center. I went down the stairs with a guy named David Frank. David was from our corporate office in California, and David and I were going to be conducting sales seminars that day, teaching some resellers how to sell our products. And we got down to about the 50th floor, so David was there to talk about the the pricing and so on. I was going to do the majority of the presentation because I was going to be their technical contact, anyway, and we got to about the 50th floor, going down, and suddenly David said, "Mike, we're going to die. We're not going to make it out of here. And as I tell people, since I got a teaching credential, I had learned all about the secrets of how to yell at students. So I just said, "Stop it, David. If Roselle and I can go down these stairs, so can you. And he then immediately said that I brought him out of his spunk, and he told me that later as well. But what he told me was that he wanted to walk a floor below me on the stairs and shout up to me everything that he was seeing. He had to take his mind off of what was going on, and so he asked if I cared, and I said, "No, go ahead. That's what you need to do. That's fine. So I got like down to the 48th floor, and he yelled, "47th floor, Mike. All's clear here. Going on down. So we went down several floors that way. Eventually, I got to 45, and he was 44th floor. This is where the Port Authority cafeteria is not stopping. And the reason I mention it is because I think what David did is one of the unsung things that is so important from September 11th. He kept shouting up to me everything that he saw, but the reality is, anyone in the sound of his voice heard that there was someone who was okay going down the stairs, and he had to keep panic out of people's senses for so many individuals, because they just heard him, Mike, 43rd floor, all's good here. Going on down the stairs, all the way down the stairs. He had to have been able to keep so many people focused because he was able to keep his mind off of what was going on by shouting to me, and I think that that's so important, and so I'm. I always tell that story. I've been telling it for many years now because I want people to know what he did to keep so many people focused going down the stairs, and he had to have done that. Bob Ellis  57:31 Well, you know, I have. That's that's the first I've heard that, and and and and I read everything that I followed your story very closely, as well as the colonel who I was so close to, but there there are a couple of stories that are just never mentioned, not talked about, and one of them where we had to do every day. There was an update that the military gave the families an update as to what is happening, what was found, what was recovered, what to expect, and they would bring the kids in to listen to these brutal military briefings. I mean, just you know, these were these were soldiers, these were these were combat folks, and this is the way they briefed. And the therapy dogs were brought in, and there wasn't but about a dozen of them, and I will never forget not only the kids on the floor with the arms around those dogs, but some of the adults were as well. And I thought, what what a moment! That was the most touching moment of my entire life witnessing that. I mean, I could have done without it, but it was it was a very special moment. And then the the other thing that the world doesn't know about is on the second day, I got a I got a phone call from Secretary Rumsfeld's office that the VA was completely out of coffin flags. We had nothing in inventory to to cover the remains or the caskets for burial, and what could I do? And and right right from the Pentagon parking lot, I I called one of the buyers that bought American flags in Dallas, and then I asked her who do you get flags from, and she says it's American Flag Company. I'll give them credit for that, and and I said you need you need to get their entire inventory. We need to get it flown in, whatever expenses cover it, and get them here. The Pentagon doesn't have them, and New York doesn't have them. And those flags came in. They were they were there about that midnight that that that night. Now boxed up, thrown in the bag box, whatever tape they were bound, but everybody that came out later, you know, the recoveries as we got deeper into the debris, that had a had a flag that that came that came from us in the as well as at the Pentagon, and they put two very big special flags in there. I mean, like you see flying over a car dealer. And they hung that on the side of the Pentagon. And if you look at any of the any of the news willers of that time, it was on day two that flag was hanging that that came in with the rest of the other flags. So it was it was quite impressive. You never know what the next moment was going to bring you on you know from my side and and and can I meet the challenge? That was what I constantly worry about. How could I let any of this down? And I've got to do something. And and we were making it up as we went along. Michael Hingson  1:00:33 Yeah, that's all you could do. And so when I go back to Bob Ellis  1:00:37 to to this to this day, you know, we go back. They've got 184 markers. I don't know how many people attend it, but it's it's right in that zone, right outside the building, in that grassy area where they they they've made that memorial. And 184 people, to include I think two infants, are are memorialized there forever, which is very touching. It was a that was a hard place to go back to. Still was New York City when I went to it because I'd never I had never been 20 years 20 years yet 18 years before I ever went to to New York City to see the recovery there. I've never I've not been to the to the to the Pennsylvania field. I plan to go. I want to go. Just hadn't been convenient to get there, but but if I do that, I will have seen all all the sites. Michael Hingson  1:01:26 Yeah, I haven't been to Pennsylvania either. In 2017, I did make it to the World Trade Center Museum. In well, so we moved out of Westfield, and I moved back to California in late January, beginning of February of 2002, to work for Guide Dogs for the Blind and and speak from there. And traveled around and speak. Karen was there for a couple more months selling our home, and then she came out. But in May of 2002, Roselle was going to be honored by Hart's Mountain, the pet food and pet supply company. So, so we went back to New York, and while we were there, I met one of the police officers with with one of the service with one of the rescue dogs that that had been around the World Trade Center, and he arranged for us to get in a vehicle and drive down into the pit that was where the World Trade Center was, and they had built an artificial, well, a temporary road, and they were bringing things up, but we got to go down to what would have been the seventh sublevel, the bottom of the tower, and it was just a for me just imagining it standing in that dirt area in a hole seven stories deep and remembering what what it was like, and then in 2017 I went to the World Trade Center Museum and got to spend a little bit of time there, and of course everything had been rebuilt. The reflecting pool was there, and so on. But it was nothing like what I remembered from having been in the World Trade Center, and I walked around with someone who was able to be aware and describe what was where we were and what was above us, or what part of the building we were in as we walked through the complex. But of course, it was totally different. So it was it was such a strange feeling to experience all of that. But we did it, you know. And so now I've been to the museum, and actually there is a there's an animal exhibit in the basement, and Roselle's collar is is part of that exhibit. We donated that to oh Bob Ellis  1:03:50 really, oh really, oh God, I I was I was thinking that when I asked you that question earlier today, and I was thinking about that that has got to be remarkable, you know that that that's what touched me so much at the period. That the fact that the two of you were such a team, and I read everything that newspapers printed and watched. I guess there was some there was some CBS specials and so forth too, where you were interviewed, and it was it was just it was just absolutely amazing. Michael Hingson  1:04:21 Well, it is. you know, it is a an awe-inspiring sort of thing. And you know, people always say, you know, don't you feel guilty about surviving when so many people didn't? And and I said, no, I I didn't have any control over that. But what I do have control over is having been a survivor. What am I going to do about it? It's my responsibility to decide how I'm going to deal with moving forward after something like that. And of course, the opportunity opened to travel and speak, and so I've been doing it ever since. And I believe my job is. Is to educate people about what happened on September 11th, and let them know t

Air Date: May 4, 2026 Transcript: https://tinyurl.com/bdfvsnj3 Kayla Jordan (PhD cand. University of Alabama) is a member of the Young Scholars Program of the Alabama Historical Association Speakers Bureau. She discusses her two Speakers Bureau presentations concerning ghost lore in the US South, “Control the Dead and the Dead with Control: The Social Used of Spirits in southern Ghostlore,” and “More than Ectoplasm: A Study of Civil War Memory and Southern Ghostlore.” LINKS MENTIONED IN THIS EPISODE Alabama Historical Association: https://www.alabamahistory.net/ Alabama Historical Association Speakers Bureau: https://www.alabamahistory.net/speakersbureau University of Alabama History Department: https://history.ua.edu/ Katheryn Tucker Windham: https://encyclopediaofalabama.org/article/kathryn-tucker-windham/ 13 Alabama Ghosts and Jeffrey: https://archive.org/details/13alabamaghostsj0000wind Mississippi State Meridian: https://www.meridian.msstate.edu/ Mississippi State: https://www.msstate.edu/ Tiya Miles' Tales from the Haunted South: https://uncpress.org/9781469636146/tales-from-the-haunted-south/ Marengo County: https://encyclopediaofalabama.org/article/marengo-county/ Half Acre, AL: https://en.wikipedia.org/wiki/Half_Acre,_Alabama Bluff Hall (Museum): https://encyclopediaofalabama.org/article/bluff-hall/ Dr. Eugene Allen Smith: https://encyclopediaofalabama.org/article/eugene-allen-smith/ The Alabama History Podcast's producer is Marty Olliff. Founded in 1947, the Alabama Historical Association is the oldest statewide historical society in Alabama. The AHA provides opportunities for meaningful engagement with the past through publications, meetings, historical markers, and other programs. See the website www.alabamahistory.net.

Three AARP State Offices share the components of their Speakers Bureau.ND, WA, and NJ State Office staff and volunteers share how they onboard volunteers to become DIY presenters, their DIY Programs, how their Speakers Bureau is organized in assigning volunteers to present their DIY presentations, successes, and areas that they are enhancing.

Why does investing feel so emotional, even when the plan is solid? This episode explores how psychology, and not just numbers, shapes the way investors react to markets. In this episode, Larry Heller, CFP®, CDFA®, CPA, is joined by Scott Bosworth, CFA,  Head of Speakers Bureau and Vice President at Dimensional Fund Advisors, to discuss how investor behavior and common behavioral biases influence long-term investment outcomes. Scott explains why emotions often feel more powerful than logic during market swings and how those reactions are deeply rooted in human psychology, not a lack of intelligence or discipline.  The conversation also explores the tension between efficient markets and behavioral finance, and why understanding both is essential to staying invested through market cycles. Throughout the episode, Scott shares practical analogies and real-world examples that help investors better recognize their own biases and make more resilient decisions over time. Scott discusses: What behavioral finance is and why it matters for investors The most common biases that affect decision-making, including overconfidence and hindsight bias Why market headlines and media narratives can increase anxiety How diversification and discipline help investors stay grounded during uncertainty The role advisors play in helping clients navigate emotional market cycles And more Connect with Scott Bosworth: LinkedIn: Scott Bosworth Dimensional Fund Advisors Connect with Larry Heller:  (631) 248-3600 Schedule a 20-Minute Call Heller Wealth Management LinkedIn: Larry Heller, CFP®, CDFA®, CPA YouTube: Retirement Unlocked with Larry Heller, CFP® About Our Guest: Scott Bosworth, CFA, is Head of Speakers Bureau and Vice President at Dimensional Fund Advisors. He has been with the firm since 1996 and brings decades of experience as a portfolio manager, institutional and advisory consultant, and trusted resource for advisors navigating market behavior and long-term investing principles.

Oral Alpan, MD, Immunologist, Amerimmune, Virginia, USA; Svenja Keller, PhD student, University of Zurich, Switzerland; Shoshana Revel-Vilk, MD, PhD, Director, Gaucher Unit & Pediatric Hematology/Oncology Unit, Shaare Zedek Medical Center, Jerusalem, Israel; Patrick Deegan, MD, Consultant Metabolic Physician, University of Cambridge, UK; and Ravi Kamath, MD, PhD, Head of Musculoskeletal Radiology, Inova Health System, Virginia, USA, discuss the applications of AI in the diagnosis and treatment of lysosomal disorders.This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare CE, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available to other attendees.To obtain CME/CE credit, visit https://checkrare.com/learning/p-grids2025-session4-expanded-applications-of-ai-in-lysosomal-disorders/Learning ObjectivesDescribe how emerging AI and machine learning technologies are advancing disease modeling and biomarker development.Describe how emerging AI and machine learning technologies are advancing therapeutic target identification across lysosomal disorders.FacultyOral Alpan, MD, Immunologist, AmerimmuneSvenja Keller, PhD student, University of ZurichShoshana Revel-Vilk, MD, PhD, Director, Gaucher Unit & Pediatric Hematology/Oncology Unit, Shaare Zedek Medical CenterPatrick Deegan, MD, Consultant Metabolic Physician, University of CambridgeRavi Kamath, MD, PhD, Head of Musculoskeletal Radiology, Inova Health SystemDisclosuresAffinityCE staff, LDRTC staff, planners, and reviewers, have no relevant financial relationships with ineligible companies to disclose. Faculty disclosures, listed below, will also be disclosed at the beginning of the Program.Oral Alpan, MD Dr. Alpan has no relevant financial relationships to disclose.Svenja KellerMs. Keller has no relevant financial relationships to disclose.Shoshana Revel-Vilk, MD, PhDDr. Revel-Vilk receives grant/research support from Sanofi and Takeda. She is a member of the Speakers Bureau for Sanofi and Takeda, and a member of the Advisory Board for Takeda.Patrick Deegan, MDDr. Deegan is a consultant and advisory board member with Sanofi, Takeda, and Amicus.He also receives research support from Sanofi and Amicus.Ravi Kamath, MD, PhDDr. Kamath is on an advisory board for Intrinsic Therapeutics. He is also a consultant forSanofi, Takeda, and Spur Therapeutics.Mitigation of Relevant Financial RelationshipsAffinityCE adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Conflicts of interest for presenting faculty with relevant financial interests were resolved through peer review of content by a non-conflicted reviewer.Accreditation and Credit DesignationPhysiciansThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.AffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Physician AssistantsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity.NursesAffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation (ANCC). This activity provides a maximum of 1 hours of continuing nursing education credit.Nurse PractitionersAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.Genetic CounselorsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Genetic Counselors should claim only the credit commensurate with the extent of their participation in the activity.Other ProfessionalsAll other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity. Participation CostsThere is no cost to participate in this activity.CME InquiriesFor all CME policy-related inquiries, please contact us at ce@affinityced.comSend customer support requests to cds_support+ldrtc@affinityced.com

David sits down with Dr. Jennifer Cramer, Director of the Appalachian Studies Program at the University of Kentucky and a Professor in the department of Linguistics to talk about the myths and realities of Appalachian Englishes. They talk about her research into dialects in Kentucky and Appalachia and how Appalachian English dialects are similar and different from other American English dialects, and how that influences the ways people think about the region. They also discuss her work with the Kentucky Humanities Council and participation in the Speakers Bureau, a program that provides high-quality speakers to libraries and other non-profits.Thank you for joining us on Tales from the Kentucky Room this year!

This special Veterans Day episode of Tips from Trestle features Navy Petty Officer First Class Michael Lammey, who survived a catastrophic boiler explosion aboard the USS Frank Cable that left him with third-degree burns over 48% of his body. After enduring more than 50 surgeries, Michael transformed his life-altering experience into hope through Folds of Honor's Speakers Bureau, sharing his story to honor fallen service members and educate audiences about military sacrifice. We explore how Folds of Honor has awarded over $340 million in scholarships to families of fallen or disabled military members and first responders since their inception in 2007. The episode also features Marc Mosley from Ben E Keith Foods discussing their eight-year partnership supporting Folds of Honor's mission. Learn how the work Folds of Honor does creates a lasting impact for military & first responder families facing unimaginable challenges and discover ways to support this life-changing organization.​​​To Support Folds of Honor, please check out their website at http://www.foldsofhonor.org/Tips from Trestle is sponsored by: eMenuChoice: https://bit.ly/TFT_eMenuWiseOx: https://bit.ly/TFT_WiseOxBen E Keith Foods: https://bit.ly/TFT_BEKAdvantageTrust GPO: https://bit.ly/TFTAdvTrust#TFT439 #VeteransDay #FoldsOfHonor​​ #MilitaryFamilies​ #VeteranSupport #HonorTheirSacrifice​ #ThankYouVeterans​ #Scholarships​ #SupportOurVeterans​ #MilitaryHeroes​ #VeteransDay2025​

On this BONUS EPISODE of CASCADE OF HISTORY, Feliks Banel speaks with Mariana Imaz, program manager of the Speakers Bureau for Humanities Washington. The Speakers Bureau provides a range of topics and speakers covering arts, culture, history - and so much more - and non-profit groups and public agencies around the Evergreen State can submit applications to request speakers to appear in their communities. Humanities Washington just released the list of speakers and topics available for 2026-2027. Deadline for applications to request a speaker for First Quarter 2026 is November 15, 2025. Humanities Washington website for more information for groups requesting speakers: https://www.humanities.org/programs/speakers-bureau/host-a-speaker/ Humanities Washington Speakers Bureau 2026-2027 Roster https://www.humanities.org/programs/speakers-bureau/upcoming-speakers/ Humanities Washington Calendar of Upcoming Events: https://www.humanities.org/events/ Feliks Banel's 2026-2027 Presentation Description - All Over The Map: https://www.humanities.org/speaker/feliks-banel-3/ CASCADE OF HISTORY is broadcast LIVE most Sunday nights at 8pm Pacific Time via SPACE 101.1 FM in Seattle and gallantly streams everywhere via www.space101fm.org. The radio station is located at historic Magnuson Park - formerly Sand Point Naval Air Station - on the shores of Lake Washington in Seattle. Subscribe to the CASCADE OF HISTORY podcast via most podcast platforms and never miss an episode.

Air date: July 7, 2025 Alabama Historical Association president for 2025-2026, Dr. Matthew Downs, discusses the AHA's program for the upcoming year. He describes the October 24-25, 2025 Fall Pilgrimage in Guntersville and the April 9-11, 2026 annual meeting in Fairhope. Downs also talks about the importance of the Alabama Review that he edits and two AHA projects – the Speakers Bureau and the AHA Digitally Enhanced Marker map. Transcript here: https://tinyurl.com/mw79d3ms Links mentioned in the episode Alabama Historical Association: https://www.alabamahistory.net/ Alabama Review: https://www.alabamahistory.net/the-alabama-review Downs's book Transforming the South: https://lsupress.org/9780807157145/transforming-the-south/ Alabama History Podcast Episode 15 (Downs on Transforming the South): https://soundcloud.com/alabamahistory/aha-015 Guntersville Historical Society: https://www.facebook.com/guntersvillehistoricalsociety/ Alabama History Podcast Episode 71 (Guntersville Historical Society): https://soundcloud.com/alabamahistory/aha-071 Lisa Shaul's book Midnight Cry: https://ugapress.org/book/9781588385338/midnight-cry/ Fairhope, AL: https://www.fairhopeal.gov/ Coastal Alabama Community College Fairhope Campus: https://www.coastalalabama.edu/about/locations/fairhope/ Explore the Eastern Shore: https://www.exploreeasternshore.com/ AHA Speakers Bureau: https://www.alabamahistory.net/speakersbureau AHA Digitally Enhanced Marker Project: https://www.alabamahistory.net/historical-markers-index Alabama Heritage Magazine: https://www.alabamaheritage.com/ Encyclopedia of Alabama: https://encyclopediaofalabama.org/ Alabama Men's Hall of Fame: https://www.samford.edu/alabama-mens-hall-of-fame/Default Alabama Women's Hall of Fame: https://awhf.org/ The Alabama History Podcast's producer is Marty Olliff. Founded in 1947, the Alabama Historical Association is the oldest statewide historical society in Alabama. The AHA provides opportunities for meaningful engagement with the past through publications, meetings, historical markers, and other programs. See the website www.alabamahistory.net.

Dr. Jeanette MacLean, a trailblazer in minimally invasive SDF practices, joins Dr. Joel Berg to discuss how observations and a willingness to try a different approach can positively benefit both providers and patients. Dr. MacLean shares how her own learning experiences seeing the same patients year after year in private practice led to her desire to consider less aggressive treatment options. She also delves into how the collaborative pediatric dental community was imperative in guiding her path. Guest Bio: Dr. Jeanette MacLean has been in private practice as an Owner for 20 years. As an appointee to the American Academy of Pediatric Dentistry's Speakers Bureau and has provided lectures across the United States, Canada, and Mexico, as well as webinars viewed in over 40 countries. Dr. MacLean graduated summa cum laude with a Bachelor of Science in Chemistry from Northern Arizona University in 1999. She received her dental degree, with honors, from the University of Southern California in 2003 and completed her specialty training in pediatric dentistry in 2005 at the Sunrise Children's Hospital through the University of Nevada School of Medicine. Dr. MacLean is a Fellow of the American Academy of Pediatric Dentistry, Fellow of the American College of Dentists, Fellow of the Pierre Fauchard Academy, and Diplomate of the American Board of Pediatric Dentistry. Her research has been published in the journals Pediatric Dentistry, the Journal of Clinical Pediatric Dentistry, the British Dental Journal, and Compendium. She has been featured twice in the New York Times: She is also an active member of the Central Arizona Dental Society, the Arizona Dental Association, the American Dental Association, the Arizona Academy of Pediatric Dentistry and the American Academy of Pediatric Dentistry. She is married to Timothy Budd, an attorney, and they have a son, Charlie, and a daughter, Sabrina. She has donated her time to underprivileged children both locally and in Mexico, Belize, and Costa Rica, and has been honored for her volunteer work and humanitarian achievements. She speaks conversational Spanish, and her interests include party planning, crafts, Jazzercise and all things Disney. She is also active in Local First Arizona, the Arizona Dental Associations' AHCCCS Subcommittee and Women in Dentistry group. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

TITLE:The Speaker Effect (ft. Amy Eddy | SVP & Strategic Account Advisor | BigSpeak Speakers Bureau) GUEST BIO:Amy Eddy is a Senior Vice President and Strategic Account Advisor, where she advocates for her clients, empowers them to make the right investment and is energized by the potential of the human spirit. A Westmont College graduate with dual business and social science degrees, Amy excels under pressure—once securing a keynote speaker with only 4 hours notice. OPENING QUOTE:“What's that one thing you want them to walk away with and not do it based on maxing out the budget. But what's going to be the most effective, the most helpful? My dream is when a client calls me and says, remember who we had two years ago, three years ago? You know that like you said about Kevin, you know, that's when I know this person is really good at what they do. When my Client remembers their name and actually remembers how they made them feel or gave them that insight that has stuck with them years later.” SUMMARY:Welcome back to another episode of No More Bad Events. Today, Scott sits down with Amy Eddy, a seasoned speaker bureau agent from Big Speak with over 18 years in the events industry. Tune in as they pull back the curtain on what really goes into planning memorable events, from the evolving role of technology and AI in the speaker business to the crucial art of choosing the right keynote speaker.You'll get a candid look at the behind-the-scenes decision-making, including why some speakers leave a lasting impression, how to balance entertainment and impact on the main stage, and what clients often overlook when building their event lineup. Plus, Amy shares anecdotes from her own extensive experience—think Roombas on the loose, last-minute speaker scrambles, and why the human touch still matters in our high-tech world.Whether you're booking your next big conference or just curious about what makes events truly unforgettable, get ready for expert insights, a few laughs, and plenty of actionable tips straight from two pros who know how to keep both audiences and event planners engaged. AUDIOGRAM[19:29-20:08]:And so when we come in and start to partner with them, we got to get them to shift, shift gears and think about like after the event is over, what do you want to be happening? And I think that just for a lot of people, they're just not thinking that way. Right. They've got a hundred things to do regarding this conference. This is one piece of it. It's super stressful. It's a lot of money. I mean, literally, people can lose jobs for hiring the wrong person. So it can be really stressful. So that's a challenge that we have. And I think an important job that we do is to get them thinking about what about after, what do you want to be going on after? And then we'll backtrack from there to figure out who's the right fit. HIRE THEM TO SPEAK:Follow Amy Eddy: linkedin.com/in/amy-eddy-3588b65Follow Scott Bloom: eSpeakers BioFollow eSpeakers: eSpeakers Marketplace ABOUT NO MORE BAD EVENTS:Brought to you by eSpeakers and hosted by professional emcee, host, and keynote speaker Scott Bloom, No More Bad Events is where you'll hear from some of the top names in the event and speaking industry about what goes on behind the scenes at the world's most perfectly executed conferences, meetings, and more. Get ready to learn the secrets and strategies to help anyone in the event industry reach their goal of putting on nothing less than world-class events.Learn more at nomorebadevents.com ABOUT THE HOST:A veteran comedian and television personality who has built a reputation as the go-to choice for business humor, Scott has hosted hundreds of events over two decades for big and small organizations alike. Scott has also hosted his own weekly VH1 series and recently co-hosted a national simulcast of the Grammy Awards from the Palace Theater.As the son of a successful salesman, he was exposed to the principles of building a business at an early age. As a comedian, Scott cut his teeth at renowned improv and comedy clubs. As a self-taught student of psychology, he's explored what makes people tick and has written a book (albeit a farce) on how to get through life. He's uniquely positioned to deliver significant notes on connecting people and making business seriously funny. And who doesn't like to laugh?Learn more about Scott: scottbloomconnects.com PRODUCED BY eSpeakers:When the perfect speaker is in front of the right audience, a kind of magic happens where organizations and individuals improve in substantial, long-term ways. eSpeakers exists to make this happen more often.eSpeakers is where the speaking industry does business on the web. Speakers, speaker managers, associations, and bureaus use our tools to organize, promote, and grow successful businesses. Event organizers think of eSpeakers first when they want to hire speakers for their meetings or events.The eSpeakers Marketplace technology lets us and our partner directories help meeting professionals worldwide connect directly with speakers for great engagements.Thousands of successful speakers, trainers, and coaches use eSpeakers to build their businesses and manage their calendars. Thousands of event organizers use our directories every day to find and hire speakers. Our tools are built for speakers, by speakers, to do things that only purpose-built systems can.Learn more at eSpeakers.com. SHOW CREDITS:●     Scott Bloom: Host | scottbloomconnects.com●     Joe Heaps: eSpeakers | jheaps@eSpeakers.com

In this episode, AARP Roost News Team member Curt Springstead speaks with representatives of AARP Do It Yourself and Do It Yourself Plus programs better known by their abbreviations DIY and DIY +. These programs are designed to help states create Speakers Bureau programs to share information of value to the 50+ community.

The Robyn Engelson Podcast Ever wish you had a wellness mentor with over decades of experience whispering million dollar health tips in your ear? That's exactly what you will get each week when you tune into The Robyn Engelson Podcast. I'm your host–a sought after autoimmune and wellness expert, corporate drop-out turned serial entrepreneur, and lifestyle transformer. Each week, I'll be bringing you inspiring guests, insights, and mindset tools to empower you to be energized, compress time, and start living instead of existing. Episode Title: Feeling Stuck at Work? [It Might Be Time for a Change!] Host: Robyn Engelson Guest: Kelly Rossi Episode Summary: In this episode, we sit down with Kelly Rossi to explore her incredible career journey—starting in affiliate marketing, transitioning into corporate America, and ultimately returning to her entrepreneurial roots in small business. Kelly shares the pivotal moments that shaped her path, from navigating the economic downturn in 2008 to working in the online lending industry, and eventually joining TransUnion after her company was acquired. She also opens up about the life-changing impact of meeting keynote speaker Lindsay Shook, how that connection led her to co-create a boutique female speakers bureau, and why she's passionate about supporting women in business. Now, having recently transitioned back to the small business world, Kelly describes the experience as refreshing—a place where her ideas are not only heard but also implemented. She shares the stark contrast between corporate life and entrepreneurship and why she believes some people are built for one over the other.   You'll learn: How Kelly entered affiliate marketing during the 2008 economic downturn The transition from small business to corporate America and what she learned The unexpected challenges of working in a corporate structure vs. small business The importance of an environment that values creativity and innovation How a keynote speaker changed her career trajectory The creation of a boutique female speakers bureau The joy of returning to small business, where ideas are heard and acted upon   Memorable Quotes: "I never in a million years thought I'd be in corporate America—and I don't think I'll ever go back." "Small businesses thrive on big ideas, but in corporate America, you have to learn to play the game." "Being in a place where my ideas are not just heard but implemented—it's refreshing!"   Resources & Mentions: Women Work F***ing Hard (Lindsay Shook's Organization) TransUnion & Corporate Experience Boutique Female Speakers Bureau   Actionable Steps for Listeners: Identify Where You're Stuck: Take a moment to evaluate if you're feeling “stuck” in your current work environment, whether it's corporate or entrepreneurial. Acknowledge whether you're going through the motions or if you're passionate about the work you're doing. Consider Change: If you feel uninspired, think about what small changes could make a big impact. Maybe it's speaking up more, suggesting ideas, or even considering a switch to a different work environment, such as a smaller, family-owned business or an entrepreneurial venture. Share Your Ideas: If you have an idea, share it with those around you. It might be with your team, your boss, or a mentor. Be bold and confident about it—you never know when it will be received well and put into action, just like in the story shared in the podcast. Take Action: Once your idea is heard, take action to help implement it. Be proactive in bringing your vision to life, as this can lead to personal growth and new opportunities. Find Your Authenticity: Reflect on whether you feel comfortable being your true self at work. If you're in an environment that allows you to be authentic, embrace it. If not, explore ways to bring more of your true self to what you do.   Final Thought: The feeling of being “stuck” is common, but there's always room for change. Whether you're in a corporate setting or a small business, it's crucial to find a place where you can share your ideas, have them valued, and take action. When you're able to be your authentic self and contribute meaningfully, everything feels refreshing. Never underestimate the power of a change in environment or mindset—it can light up your entire career and life.   What listeners have to say: “Her energy is fire! I love being able to apply her simple strategies and life tips to my daily life to be energized instead of existing.”   Loved this episode? If you found value in this conversation, don't forget to leave a review! Scroll to the bottom, tap to rate with five stars, and select “Write a Review.” Your feedback helps us create content that supports your journey to thriving, not just surviving.   Connect with Kelly Rossi: LinkedIn   About Kelly Kelly Rossi has15 years of expertise in the financial sector specifically in the lending industry, specializing in alternative data, portfolio management, and affiliate marketing. Outside of work, Kelly lives in the Chicago suburbs with her husband and two daughters Isabella (5) and Reagan (2). She's not only a dedicated professional but also an entrepreneur, owning a speakers bureau called BellaFord and a networking group called ‘Women Work F'ing Hard'. On top of that, she serves on her local PTA board and coaches her daughter's sports.  In her free time, she enjoys being with friends and family, good wine, and good food!   Connect with Robyn: Get Robyn's #1 best selling book, Exhausted To Energized - 90 Days To Your Best Self  Get Robyn's free video  Sign up for Robyn's personal letter  View Robyn's website Follow Robyn on LinkedIn Robyn's Facebook Watch Robyn on Instagram    

In this episode, Laura Cassiday and Joanna Wachowiak-Finlaison chat and chuckle with Dr. Denise Johnson about house soiling issues in cats.Dr. Denise Johnson is a general practitioner of veterinary medicine and an International Association of Animal Behavior Consultants (IAABC) Certified Cat Behavior Consultant. Her special interests include behavioral health and low-stress handling. Her qualifications include Elite Fear Free Practitioner, Certified in Low Stress Handling–Silver, and Cat Friendly Veterinarian Certifications. In addition to being a certified member of the IAABC, she serves on their Ethics Committee and as a peer reviewer for the IAABC Journal. Dr. Johnson offers remote behavior consulting, vet-to-vet consultation, and is a member of the AVSAB's Speakers Bureau. She spends her free time working on Committed to Claws, an education project that provides pet owners and pet professionals with resources to reduce the incidence of onychectomy.

Blair began his career in New York at the HarperCollins Speakers Bureau, a business he never knew existed. From there, he had the privilege of leading the Hachette and Simon & Schuster Speakers Bureaus for GTN (now UTA Speakers), before moving west to work with Keith Ferrazzi (author of "Never Eat Alone"). He served as his chief of staff for over three years and learned how keynote speaking can be strategically positioned for corporate coaching and consulting while also studying at UCLA Anderson.After a few temporary roles during his last year of business school, he returned to the Speakers Bureau world post-graduation. However, after signing and establishing talent, growing and scaling valuable assets and businesses for bosses with nothing to show for it after leaving, he had had enough.In today's episode of Smashing the Plateau, you will learn about the intricacies of the speakers bureau industry and how to leverage speaking engagements for business growth and personal success.Blair and I discuss:His journey from working at traditional speakers bureaus to founding his own firm [00:21]What initially drew him to the speakers bureau industry [01:49]The business model behind speakers bureaus and how they operate [03:00]His decision to pursue an MBA and how it influenced his career [04:11]The challenges of working under restrictive leadership and the push towards entrepreneurship [07:50]The strategic positioning of keynote speaking in business development [00:43]How his business model differs from traditional speakers bureaus and the focus on holistic client management [11:18]Advice for corporate refugees on leveraging speaking engagements [13:39]Learn more about Blair at https://calendly.com/bbn-cm/new-client-call.Thank you to Our Sponsors:The Smashing the Plateau CommunityConnect with us for insightful strategy tips from our experts, designed to help you master your success journey effortlessly.

In this insightful episode, Jessica Dumas breaks down the true value of public speaking and why it's more than just a hobby—it's a powerful industry. Jessica highlights how public speaking can help entrepreneurs and thought leaders build authority, promote their businesses, and create additional income streams. She explains the profound impact of storytelling and inspiration, showing how sharing your experiences can help others see what's possible. Jessica also emphasizes that public speaking isn't reserved for elected leaders or those with large audiences—it's for anyone ready to share their message and make a lasting impression. For those looking to transition from honorariums to commanding premium fees, Jessica walks through the mindset shift required to recognize the value of expertise. She also shares practical advice on setting speaking fees and scaling up as experience grows. What Jessica Covers: Reframing Public Speaking: Why speaking is a $1.9 billion industry (and growing annually at 4.1%). Inspiration Through Speaking: The power of storytelling to inspire and create meaningful connections. Building Credibility: How having an opinion and sharing it boldly makes you a thought leader. From Honorariums to Premium Fees: The journey to valuing your expertise and commanding higher fees. How to Set Your Speaking Fee: A starting point and guide for scaling your rates over time. Key Points from the Episode: Public speaking is a powerful way to inspire and build trust with an audience. It's a tool to establish authority, generate premium opportunities, and grow your business. Starting with a baseline fee (e.g., $1,000) and increasing it as your expertise grows helps you position yourself as a professional. Present your fee with confidence—it's a service and a reflection of your value. Quick Fee Tips: Start small and scale up based on experience and audience size. Industry standards, such as rates from the Speakers Bureau of Canada ($7,500–$20,000), can guide you. Approach your speaking fees as a business item—structured and professional. Connect with Jessica Dumas: Jessica invites listeners to connect with her for more insights and opportunities: Follow Jessica on Instagram for daily inspiration and behind-the-scenes content: @jessicadumas.ca Interested in professional growth or mindset coaching? Learn about her services here: Work with Jessica. Call to Action: Jessica encourages listeners to see public speaking as a pathway to deeper connections, personal growth, and professional success. Whether you're starting out or looking to refine your speaking career, Jessica can help you clarify your goals, amplify your voice, and step into premium opportunities. Reach out today!

MVP host Dan Smith interviews Amy Mallinger, the founder of the REACH ("Remember, Educate, and Combat Hate") speakers bureau at the 10.27 Healing Partnership in Pittsburgh. Following the Pittsburgh synagogue shootings, survivors and victims' family members created REACH as a way to educate about anti-Semitic and other hate-based mass violence by putting real faces on these incidents through sharing their stories with students and communities. https://1027healingpartnership.org/reach/

This week, Muslims across the world celebrate the holiday of Eid-al-Adha or the Feast of Sacrifice. Today, we are hearing from Muslims around Connecticut celebrating this sacred and special time honoring those who have made the Islamic pilgrimage known as Hajj. We'll hear from Connecticut residents, including one who is making the Islamic pilgrimage known as Hajj. If you're celebrating this holiday, we want to hear from you. GUESTS: Khaleel Rahman: a producer with Audacious with Chion Wolf on Connecticut Public Imam Safwan Shaikh: Farmington Valley American Muslim Center Asif Chaudhry: Connecticut resident taking a Eid-al-Adha pilgrimage this year Dia Fortenberry: Assistant Athletic Director of Diversity, Equity, Inclusion and Engagement at Wesleyan University and Speakers Bureau with the Muslim Coalition of Connecticut Where We Live is available as a podcast on Apple Podcasts, Spotify, Amazon Music, TuneIn, Listen Notes, or wherever you get your podcasts. Subscribe and never miss an episode.Support the show: http://wnpr.org/donateSee omnystudio.com/listener for privacy information.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GJM865. CME/MOC/AAPA/IPCE credit will be available until March 12, 2025.A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient Populations In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Genentech, a member of the Roche Group, and Novo Nordisk Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerAmy Shapiro, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Be Biopharma; BioMarin; Genentech, Inc./F. Hoffmann-La Roche Ltd; HEMA Biologics, LLC; Kedrion Biopharma Inc.; Novo Nordisk Inc.; Pfizer; and Sanofi-Genzyme.Grant/Research Support from Agios Pharmaceuticals, Inc.; BioMarin; Genentech, Inc./F. Hoffmann-La Roche Ltd; Kedrion Biopharma Inc.; Novo Nordisk Inc.; Pfizer; Regeneron Pharmaceuticals Inc.; Sanofi-Genzyme; Pharmacosmos A/S; and Takeda Pharmaceutical Company Limited.Speakers Bureau participant with Genentech, Inc./F. Hoffmann-La Roche Ltd; Kedrion Biopharma Inc.; and Sanofi-Genzyme.Other Financial or Material Support in the form as a board member of the Novo Nordisk Haemophilia Foundation. She is the Medical Director of the National Hemophilia Program and Coordinating Center of the American Thrombosis Hemostatis Network.Faculty/PlannerMaissaa Janbain, MD, MSCR, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Clovis Oncology, Inc.; Genentech, Inc.; GlaxoSmithKline; Novartis Pharmaceuticals Corporation; Pfizer; Puma Biotechnology, Inc.; Sanofi Genzyme; and Seagen Inc.Grant/Research Support from AstraZeneca; Pfizer; and Seagen Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SVX865. CME/MOC/AAPA credit will be available until March 7, 2025.Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders and the Rationale for Targeted Biologic Therapy: Focus on Moderate to Severe Atopic Dermatitis, Prurigo Nodularis, Chronic Urticaria, and Bullous Pemphigoid In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerAdam Friedman, MD, FAAD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Arcutis Biotherapeutics, Inc.; Incyte; Janssen Pharmaceuticals, Inc.; and Regeneron Pharmaceuticals Inc./Sanofi.Grant/Research Support from Incyte and Janssen Pharmaceuticals, Inc.Speaker for Bristol Myers Squibb; Incyte; Janssen Pharmaceuticals, Inc.; and Regeneron Pharmaceuticals Inc./Sanofi.Co-Chair/PlannerShawn Kwatra, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Amgen Inc.; Arcutis Biotherapeutics, Inc.; Asian Pharmaceuticals Pvt. Ltd.; Bristol Myers Squibb; Cara Therapeutics; Castle Biosciences, Inc.; Celldex Therapeutics; Dermavant Sciences, Inc.; Galderma; Genzada Pharmaceuticals USA, Inc.; Incyte; Johnson & Johnson Services, Inc.; LEO Pharma A/S; Novartis Pharmaceuticals Corporation; Pfizer; Regeneron Pharmaceuticals Inc.; and Sanofi.Grant/Research Support from Galderma; Incyte; Pfizer; and Sanofi.Co-Chair/PlannerPeter A. Lio, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Almirall, S.A.; Amyris, Inc.; AOBiome; ASLAN Pharmaceuticals Pte Ltd; Bristol Myers Squibb; Burt's Bees Products Company; Concerto Biosciences; Dermavant Sciences, Inc.; Galderma S.A.; Leo Pharma Inc.; Lilly; L'Oréal USA, Inc.; Merck & Co., Inc.; Micreos B.V.; MyOR; Pfizer; Pierre Fabre group; Regeneron Pharmaceuticals Inc./Sanofi Genzyme; Theraplex; UCB, Inc.; and Verrica Pharmaceuticals.Grant/Research Support from AbbVie Inc. and Regeneron Pharmaceuticals Inc./Sanofi Genzyme.Speakers Bureau participant with AbbVie Inc.; Galderma S.A.; Incyte; Leo Pharma Inc.; Lilly; L'Oréal USA, Inc.; Pfizer; and Regeneron Pharmaceuticals Inc./Sanofi Genzyme.Co-Chair/PlannerProfessor Dedee Murrell has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amryt Pharma plc; Castle Creek Biosciences, Inc.; Krystal Biotech; and RHEACELL GmbH & Co. KG.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GJM865. CME/MOC/AAPA/IPCE credit will be available until March 12, 2025.A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient Populations In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Genentech, a member of the Roche Group, and Novo Nordisk Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerAmy Shapiro, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Be Biopharma; BioMarin; Genentech, Inc./F. Hoffmann-La Roche Ltd; HEMA Biologics, LLC; Kedrion Biopharma Inc.; Novo Nordisk Inc.; Pfizer; and Sanofi-Genzyme.Grant/Research Support from Agios Pharmaceuticals, Inc.; BioMarin; Genentech, Inc./F. Hoffmann-La Roche Ltd; Kedrion Biopharma Inc.; Novo Nordisk Inc.; Pfizer; Regeneron Pharmaceuticals Inc.; Sanofi-Genzyme; Pharmacosmos A/S; and Takeda Pharmaceutical Company Limited.Speakers Bureau participant with Genentech, Inc./F. Hoffmann-La Roche Ltd; Kedrion Biopharma Inc.; and Sanofi-Genzyme.Other Financial or Material Support in the form as a board member of the Novo Nordisk Haemophilia Foundation. She is the Medical Director of the National Hemophilia Program and Coordinating Center of the American Thrombosis Hemostatis Network.Faculty/PlannerMaissaa Janbain, MD, MSCR, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Clovis Oncology, Inc.; Genentech, Inc.; GlaxoSmithKline; Novartis Pharmaceuticals Corporation; Pfizer; Puma Biotechnology, Inc.; Sanofi Genzyme; and Seagen Inc.Grant/Research Support from AstraZeneca; Pfizer; and Seagen Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SVX865. CME/MOC/AAPA credit will be available until March 7, 2025.Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders and the Rationale for Targeted Biologic Therapy: Focus on Moderate to Severe Atopic Dermatitis, Prurigo Nodularis, Chronic Urticaria, and Bullous Pemphigoid In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerAdam Friedman, MD, FAAD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Arcutis Biotherapeutics, Inc.; Incyte; Janssen Pharmaceuticals, Inc.; and Regeneron Pharmaceuticals Inc./Sanofi.Grant/Research Support from Incyte and Janssen Pharmaceuticals, Inc.Speaker for Bristol Myers Squibb; Incyte; Janssen Pharmaceuticals, Inc.; and Regeneron Pharmaceuticals Inc./Sanofi.Co-Chair/PlannerShawn Kwatra, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Amgen Inc.; Arcutis Biotherapeutics, Inc.; Asian Pharmaceuticals Pvt. Ltd.; Bristol Myers Squibb; Cara Therapeutics; Castle Biosciences, Inc.; Celldex Therapeutics; Dermavant Sciences, Inc.; Galderma; Genzada Pharmaceuticals USA, Inc.; Incyte; Johnson & Johnson Services, Inc.; LEO Pharma A/S; Novartis Pharmaceuticals Corporation; Pfizer; Regeneron Pharmaceuticals Inc.; and Sanofi.Grant/Research Support from Galderma; Incyte; Pfizer; and Sanofi.Co-Chair/PlannerPeter A. Lio, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Almirall, S.A.; Amyris, Inc.; AOBiome; ASLAN Pharmaceuticals Pte Ltd; Bristol Myers Squibb; Burt's Bees Products Company; Concerto Biosciences; Dermavant Sciences, Inc.; Galderma S.A.; Leo Pharma Inc.; Lilly; L'Oréal USA, Inc.; Merck & Co., Inc.; Micreos B.V.; MyOR; Pfizer; Pierre Fabre group; Regeneron Pharmaceuticals Inc./Sanofi Genzyme; Theraplex; UCB, Inc.; and Verrica Pharmaceuticals.Grant/Research Support from AbbVie Inc. and Regeneron Pharmaceuticals Inc./Sanofi Genzyme.Speakers Bureau participant with AbbVie Inc.; Galderma S.A.; Incyte; Leo Pharma Inc.; Lilly; L'Oréal USA, Inc.; Pfizer; and Regeneron Pharmaceuticals Inc./Sanofi Genzyme.Co-Chair/PlannerProfessor Dedee Murrell has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amryt Pharma plc; Castle Creek Biosciences, Inc.; Krystal Biotech; and RHEACELL GmbH & Co. KG.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GJM865. CME/MOC/AAPA/IPCE credit will be available until March 12, 2025.A Joint Effort for Equitable Hemophilia A Care: Collaborative Solutions for Enhancing Outcomes in Diverse and Challenging Patient Populations In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Genentech, a member of the Roche Group, and Novo Nordisk Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerAmy Shapiro, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Be Biopharma; BioMarin; Genentech, Inc./F. Hoffmann-La Roche Ltd; HEMA Biologics, LLC; Kedrion Biopharma Inc.; Novo Nordisk Inc.; Pfizer; and Sanofi-Genzyme.Grant/Research Support from Agios Pharmaceuticals, Inc.; BioMarin; Genentech, Inc./F. Hoffmann-La Roche Ltd; Kedrion Biopharma Inc.; Novo Nordisk Inc.; Pfizer; Regeneron Pharmaceuticals Inc.; Sanofi-Genzyme; Pharmacosmos A/S; and Takeda Pharmaceutical Company Limited.Speakers Bureau participant with Genentech, Inc./F. Hoffmann-La Roche Ltd; Kedrion Biopharma Inc.; and Sanofi-Genzyme.Other Financial or Material Support in the form as a board member of the Novo Nordisk Haemophilia Foundation. She is the Medical Director of the National Hemophilia Program and Coordinating Center of the American Thrombosis Hemostatis Network.Faculty/PlannerMaissaa Janbain, MD, MSCR, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Clovis Oncology, Inc.; Genentech, Inc.; GlaxoSmithKline; Novartis Pharmaceuticals Corporation; Pfizer; Puma Biotechnology, Inc.; Sanofi Genzyme; and Seagen Inc.Grant/Research Support from AstraZeneca; Pfizer; and Seagen Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

In this episode, Lisa and Ted discuss:What optometrists do and how they help people enhance their quality of life. Essential skills and qualities for those who will have a long and successful optometrist career Understanding the path from high school to graduate school for optometry.The competitive nature of optometry school and the state-specific regulations aspiring optometrists must navigate. Key Takeaways: Optometrists work with all ages, including infants, to catch any vision issues.Ophthalmology and Optometry have different but equally rigorous requirements. Optometrists work closely with Ophthalmologists for advanced eye care needs.Optometry school is very competitive; strong grades in science courses are important. Consider taking sciences outside of just biology, physics, and chemistry beginning in high school if available.Laws regarding what optometrists can do vary by state, so research where your teen may want to practice. Don't rely on your student's advisor to know everything; students should do their own research.  “If you're planning on doing this, do it because you love it. Optometry is not going to make you rich. Medicine is not going to make you rich. There is never a job they will pay you enough to do. It is about doing it because you care about people, and you want to take care of people.” – Ted McElroy, O.D.About Ted McElroy, O.D.: Ted McElroy, OD, founded his practice, Vision Source Tifton, in 1994 in Tifton, GA. In 2004 he served as the Georgia Optometric Association President and in 2016 as President for SECO International. Ted was the recipient of the 1997 GA Optometric Association's (GOA) Young Optometrist of the Year, the 2005 GOA Optometrist of the Year, the 2009 GOA Bernard Kahn Award Recipient, and the 2022 GOA Georgianne Bearden Excellence in Leadership Award.Ted enjoys speaking to optometric students on the joys of private practice and assisting aspiring practice owners. He has served on the Speaker's Bureaus for Alcon, CibaVision, and VSP and is currently on the Speakers Bureau for Vision Source. He is an administrator for Vision Source and serves on the Administrator Advisory Board. Ted is an author published in Invision and Optometric Management, and has also served on the Optometric Management editorial board. He currently serves SECO International as the Chair for the MedPRO 360 committee, the Business Education Program of SECO International. Ted co-hosts the Eyecode Media Podcast with Drs. Chris Wolfe and Aaron Werner.Episode References:#005 Advice for Students Considering Medicine and Healthcare Careers   https://www.flourishcoachingco.com/podcast/5-healthcare-careers/ Get Lisa's Free on-demand video: How-to guide for your teen to choose the right major, college, & career...(without painting themselves into a corner, missing crucial deadlines, or risking choices you both regret). https://flourishcoachingco.com/videoConnect with Ted:Website: https://visionsource-tiftonfamilyeyecare.com/ LinkedIn: https://www.linkedin.com/in/tedmcelroyod/ Connect with Lisa:Website: https://www.flourishcoachingco.com/YouTube: https://www.youtube.com/@flourishcoachingcoInstagram: https://www.instagram.com/flourishcoachingco/LinkedIn: https://www.linkedin.com/company/flourish-coaching-co

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerLeonard B. Bacharier, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Aravax; AstraZeneca; Avillion LLP; DBV Technologies; GlaxoSmithKline; Kinaset Therapeutics; Regeneron Pharmaceuticals Inc.; Sanofi; and Vertex Pharmaceuticals Incorporated.Speaker for Regeneron Pharmaceuticals Inc. and Sanofi.Other Financial or Material Support for Patents and Royalties from Elsevier.Faculty/PlannerKlaus F. Rabe, MD, PhD, FERS, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; CSL Behring; Regeneron Pharmaceuticals Inc.; and Sanofi.Speakers Bureau participant with AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; The Menarini Group; Regeneron Pharmaceuticals Inc.; and Sanofi.PresenterArzu Yorgancioglu, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abdi İbrahim; AstraZeneca; CHIESI USA, Inc.; and GlaxoSmithKline.Grant/Research Support from Sanofi.Speaker for Abdi İbrahim; AstraZeneca; Bilim Pharmaceuticals; CHIESI USA, Inc.; GlaxoSmithKline; and Novartis Pharmaceuticals Corporation.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerLeonard B. Bacharier, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Aravax; AstraZeneca; Avillion LLP; DBV Technologies; GlaxoSmithKline; Kinaset Therapeutics; Regeneron Pharmaceuticals Inc.; Sanofi; and Vertex Pharmaceuticals Incorporated.Speaker for Regeneron Pharmaceuticals Inc. and Sanofi.Other Financial or Material Support for Patents and Royalties from Elsevier.Faculty/PlannerKlaus F. Rabe, MD, PhD, FERS, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; CSL Behring; Regeneron Pharmaceuticals Inc.; and Sanofi.Speakers Bureau participant with AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; The Menarini Group; Regeneron Pharmaceuticals Inc.; and Sanofi.PresenterArzu Yorgancioglu, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abdi İbrahim; AstraZeneca; CHIESI USA, Inc.; and GlaxoSmithKline.Grant/Research Support from Sanofi.Speaker for Abdi İbrahim; AstraZeneca; Bilim Pharmaceuticals; CHIESI USA, Inc.; GlaxoSmithKline; and Novartis Pharmaceuticals Corporation.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerLeonard B. Bacharier, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Aravax; AstraZeneca; Avillion LLP; DBV Technologies; GlaxoSmithKline; Kinaset Therapeutics; Regeneron Pharmaceuticals Inc.; Sanofi; and Vertex Pharmaceuticals Incorporated.Speaker for Regeneron Pharmaceuticals Inc. and Sanofi.Other Financial or Material Support for Patents and Royalties from Elsevier.Faculty/PlannerKlaus F. Rabe, MD, PhD, FERS, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; CSL Behring; Regeneron Pharmaceuticals Inc.; and Sanofi.Speakers Bureau participant with AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; The Menarini Group; Regeneron Pharmaceuticals Inc.; and Sanofi.PresenterArzu Yorgancioglu, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abdi İbrahim; AstraZeneca; CHIESI USA, Inc.; and GlaxoSmithKline.Grant/Research Support from Sanofi.Speaker for Abdi İbrahim; AstraZeneca; Bilim Pharmaceuticals; CHIESI USA, Inc.; GlaxoSmithKline; and Novartis Pharmaceuticals Corporation.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerLeonard B. Bacharier, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Aravax; AstraZeneca; Avillion LLP; DBV Technologies; GlaxoSmithKline; Kinaset Therapeutics; Regeneron Pharmaceuticals Inc.; Sanofi; and Vertex Pharmaceuticals Incorporated.Speaker for Regeneron Pharmaceuticals Inc. and Sanofi.Other Financial or Material Support for Patents and Royalties from Elsevier.Faculty/PlannerKlaus F. Rabe, MD, PhD, FERS, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; CSL Behring; Regeneron Pharmaceuticals Inc.; and Sanofi.Speakers Bureau participant with AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; The Menarini Group; Regeneron Pharmaceuticals Inc.; and Sanofi.PresenterArzu Yorgancioglu, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abdi İbrahim; AstraZeneca; CHIESI USA, Inc.; and GlaxoSmithKline.Grant/Research Support from Sanofi.Speaker for Abdi İbrahim; AstraZeneca; Bilim Pharmaceuticals; CHIESI USA, Inc.; GlaxoSmithKline; and Novartis Pharmaceuticals Corporation.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerLeonard B. Bacharier, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Aravax; AstraZeneca; Avillion LLP; DBV Technologies; GlaxoSmithKline; Kinaset Therapeutics; Regeneron Pharmaceuticals Inc.; Sanofi; and Vertex Pharmaceuticals Incorporated.Speaker for Regeneron Pharmaceuticals Inc. and Sanofi.Other Financial or Material Support for Patents and Royalties from Elsevier.Faculty/PlannerKlaus F. Rabe, MD, PhD, FERS, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; CSL Behring; Regeneron Pharmaceuticals Inc.; and Sanofi.Speakers Bureau participant with AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; The Menarini Group; Regeneron Pharmaceuticals Inc.; and Sanofi.PresenterArzu Yorgancioglu, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abdi İbrahim; AstraZeneca; CHIESI USA, Inc.; and GlaxoSmithKline.Grant/Research Support from Sanofi.Speaker for Abdi İbrahim; AstraZeneca; Bilim Pharmaceuticals; CHIESI USA, Inc.; GlaxoSmithKline; and Novartis Pharmaceuticals Corporation.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerLeonard B. Bacharier, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Aravax; AstraZeneca; Avillion LLP; DBV Technologies; GlaxoSmithKline; Kinaset Therapeutics; Regeneron Pharmaceuticals Inc.; Sanofi; and Vertex Pharmaceuticals Incorporated.Speaker for Regeneron Pharmaceuticals Inc. and Sanofi.Other Financial or Material Support for Patents and Royalties from Elsevier.Faculty/PlannerKlaus F. Rabe, MD, PhD, FERS, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; CSL Behring; Regeneron Pharmaceuticals Inc.; and Sanofi.Speakers Bureau participant with AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; The Menarini Group; Regeneron Pharmaceuticals Inc.; and Sanofi.PresenterArzu Yorgancioglu, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abdi İbrahim; AstraZeneca; CHIESI USA, Inc.; and GlaxoSmithKline.Grant/Research Support from Sanofi.Speaker for Abdi İbrahim; AstraZeneca; Bilim Pharmaceuticals; CHIESI USA, Inc.; GlaxoSmithKline; and Novartis Pharmaceuticals Corporation.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerLeonard B. Bacharier, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Aravax; AstraZeneca; Avillion LLP; DBV Technologies; GlaxoSmithKline; Kinaset Therapeutics; Regeneron Pharmaceuticals Inc.; Sanofi; and Vertex Pharmaceuticals Incorporated.Speaker for Regeneron Pharmaceuticals Inc. and Sanofi.Other Financial or Material Support for Patents and Royalties from Elsevier.Faculty/PlannerKlaus F. Rabe, MD, PhD, FERS, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; CSL Behring; Regeneron Pharmaceuticals Inc.; and Sanofi.Speakers Bureau participant with AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; The Menarini Group; Regeneron Pharmaceuticals Inc.; and Sanofi.PresenterArzu Yorgancioglu, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abdi İbrahim; AstraZeneca; CHIESI USA, Inc.; and GlaxoSmithKline.Grant/Research Support from Sanofi.Speaker for Abdi İbrahim; AstraZeneca; Bilim Pharmaceuticals; CHIESI USA, Inc.; GlaxoSmithKline; and Novartis Pharmaceuticals Corporation.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerLeonard B. Bacharier, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Aravax; AstraZeneca; Avillion LLP; DBV Technologies; GlaxoSmithKline; Kinaset Therapeutics; Regeneron Pharmaceuticals Inc.; Sanofi; and Vertex Pharmaceuticals Incorporated.Speaker for Regeneron Pharmaceuticals Inc. and Sanofi.Other Financial or Material Support for Patents and Royalties from Elsevier.Faculty/PlannerKlaus F. Rabe, MD, PhD, FERS, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; CSL Behring; Regeneron Pharmaceuticals Inc.; and Sanofi.Speakers Bureau participant with AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; The Menarini Group; Regeneron Pharmaceuticals Inc.; and Sanofi.PresenterArzu Yorgancioglu, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abdi İbrahim; AstraZeneca; CHIESI USA, Inc.; and GlaxoSmithKline.Grant/Research Support from Sanofi.Speaker for Abdi İbrahim; AstraZeneca; Bilim Pharmaceuticals; CHIESI USA, Inc.; GlaxoSmithKline; and Novartis Pharmaceuticals Corporation.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerLeonard B. Bacharier, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Aravax; AstraZeneca; Avillion LLP; DBV Technologies; GlaxoSmithKline; Kinaset Therapeutics; Regeneron Pharmaceuticals Inc.; Sanofi; and Vertex Pharmaceuticals Incorporated.Speaker for Regeneron Pharmaceuticals Inc. and Sanofi.Other Financial or Material Support for Patents and Royalties from Elsevier.Faculty/PlannerKlaus F. Rabe, MD, PhD, FERS, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; CSL Behring; Regeneron Pharmaceuticals Inc.; and Sanofi.Speakers Bureau participant with AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; The Menarini Group; Regeneron Pharmaceuticals Inc.; and Sanofi.PresenterArzu Yorgancioglu, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abdi İbrahim; AstraZeneca; CHIESI USA, Inc.; and GlaxoSmithKline.Grant/Research Support from Sanofi.Speaker for Abdi İbrahim; AstraZeneca; Bilim Pharmaceuticals; CHIESI USA, Inc.; GlaxoSmithKline; and Novartis Pharmaceuticals Corporation.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerLeonard B. Bacharier, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Aravax; AstraZeneca; Avillion LLP; DBV Technologies; GlaxoSmithKline; Kinaset Therapeutics; Regeneron Pharmaceuticals Inc.; Sanofi; and Vertex Pharmaceuticals Incorporated.Speaker for Regeneron Pharmaceuticals Inc. and Sanofi.Other Financial or Material Support for Patents and Royalties from Elsevier.Faculty/PlannerKlaus F. Rabe, MD, PhD, FERS, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; CSL Behring; Regeneron Pharmaceuticals Inc.; and Sanofi.Speakers Bureau participant with AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; The Menarini Group; Regeneron Pharmaceuticals Inc.; and Sanofi.PresenterArzu Yorgancioglu, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abdi İbrahim; AstraZeneca; CHIESI USA, Inc.; and GlaxoSmithKline.Grant/Research Support from Sanofi.Speaker for Abdi İbrahim; AstraZeneca; Bilim Pharmaceuticals; CHIESI USA, Inc.; GlaxoSmithKline; and Novartis Pharmaceuticals Corporation.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerLeonard B. Bacharier, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Aravax; AstraZeneca; Avillion LLP; DBV Technologies; GlaxoSmithKline; Kinaset Therapeutics; Regeneron Pharmaceuticals Inc.; Sanofi; and Vertex Pharmaceuticals Incorporated.Speaker for Regeneron Pharmaceuticals Inc. and Sanofi.Other Financial or Material Support for Patents and Royalties from Elsevier.Faculty/PlannerKlaus F. Rabe, MD, PhD, FERS, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; CSL Behring; Regeneron Pharmaceuticals Inc.; and Sanofi.Speakers Bureau participant with AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; The Menarini Group; Regeneron Pharmaceuticals Inc.; and Sanofi.PresenterArzu Yorgancioglu, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abdi İbrahim; AstraZeneca; CHIESI USA, Inc.; and GlaxoSmithKline.Grant/Research Support from Sanofi.Speaker for Abdi İbrahim; AstraZeneca; Bilim Pharmaceuticals; CHIESI USA, Inc.; GlaxoSmithKline; and Novartis Pharmaceuticals Corporation.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AGP865. CME/MOC/AAPA credit will be available until March 7, 2025.Overcoming Challenges in the Treatment of Pediatric and Adult Patients With Uncontrolled Moderate to Severe Asthma: Comparing Approaches to the Use of Targeted Biologic Therapy With Experts Around the World In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerLeonard B. Bacharier, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Aravax; AstraZeneca; Avillion LLP; DBV Technologies; GlaxoSmithKline; Kinaset Therapeutics; Regeneron Pharmaceuticals Inc.; Sanofi; and Vertex Pharmaceuticals Incorporated.Speaker for Regeneron Pharmaceuticals Inc. and Sanofi.Other Financial or Material Support for Patents and Royalties from Elsevier.Faculty/PlannerKlaus F. Rabe, MD, PhD, FERS, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; CSL Behring; Regeneron Pharmaceuticals Inc.; and Sanofi.Speakers Bureau participant with AstraZeneca; BERLIN-CHEMIE AG; Boehringer Ingelheim International GmbH; CHIESI USA, Inc.; The Menarini Group; Regeneron Pharmaceuticals Inc.; and Sanofi.PresenterArzu Yorgancioglu, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abdi İbrahim; AstraZeneca; CHIESI USA, Inc.; and GlaxoSmithKline.Grant/Research Support from Sanofi.Speaker for Abdi İbrahim; AstraZeneca; Bilim Pharmaceuticals; CHIESI USA, Inc.; GlaxoSmithKline; and Novartis Pharmaceuticals Corporation.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/XZU865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 25, 2025.Advancing Personalized Care in RCC: Navigating Rapid Therapeutic Expansion and Sequencing Strategies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Kidney Cancer Research Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through medical education grants from AVEO Pharmaceuticals, Inc., Bristol Myers Squibb, Eisai Inc., Exelixis, Inc., and Merck & Co., Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerSumanta Kumar Pal, MD, FASCO, has a financial interest/relationship or affiliation in the form of:Grant/Research Support from Allogene Therapeutics; CRISPR Therapeutics; Eisai Co., Ltd.; Exelixis, Inc.; Genentech, Inc./F. Hoffmann-La Roche Ltd.; and Pfizer all paid to institution.Faculty/PlannerPedro C. Barata, MD, MSc, FACP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Astellas Pharma Inc.; AVEO Pharmaceuticals, Inc; Bristol Myers Squibb; Clovis Oncology; EMD Serono; Eisai Co., Ltd.; Exelixis, Inc.; Ipsen Biopharmaceuticals, Inc.; Pfizer; and Sanofi.Grant/Research Support from EMD Serono and Exelixis, Inc.Speakers Bureau participant with Bayer Corporation; Caris Life Sciences; Merck & Co., Inc.; and Sanofi.Faculty/PlannerDavid F. McDermott, MD, has no financial interests/relationships or affiliations in relation to this activity.Faculty/PlannerTian Zhang, MD, MHS, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Aravive; AstraZeneca; AVEO Pharmaceuticals, Inc.; Bayer Corporation; Bristol Myers Squibb; Caris Life Sciences; Eisai Co., Ltd.; EMD Serono; Exelixis, Inc.; Gilead Sciences, Inc.; Janssen Pharmaceuticals, Inc.; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer; Sanofi; and Seagen Inc.Grant/Research Support from ALX Oncology; Janssen Pharmaceuticals, Inc.; Lilly; Merck & Co., Inc.; Pfizer; and Tempus.Other Financial or Material Support for leadership or fiduciary role in Kidney Cancer Association (KCA) Medical Steering Committee; Kidney Cancer Research Alliance (KCCure) Scientific Advisory Board; and National Cancer Institute (NCI) Steering Renal Task Force.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/GZR865. CME/MOC credit will be available until February 14, 2025.PATHway to Decoding the Impact of Cancer Immunotherapy: Latest Advances in Biomarker Testing and Pathologic Response Assessment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck & Co., Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerKurt A. Schalper, MD, PhD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Agenus Inc.; AstraZeneca; Bristol Myers Squibb; CDR-Life Inc.; Clinica Alemana de Santiago; EMD Serono Inc.; F.Hoffmann-La Roche; Genmab A/S; Indaptus Therapeutics; Janssen Pharmaceuticals, Inc.; Merck Sharpe & Dohme; Moderna, Inc.; Molecular Templates, Inc.; OnCusp Therapeutics; Parthenon/Incendia Therapeutics; Repertoire Therapeutics; Sanofi; Sensei Biotherapeutics; Shattuck Labs, Inc.; and Takeda Pharmaceutical Company Limited.Grant/Research Support from Akoya Biosciences; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; F. Hoffmann-La Roche; Lilly; Merck Sharpe & Dohme; Ribon Therapeutics; Surface Oncology; Takeda Pharmaceutical Company Limited; and Tesaro Inc./GSK.Speakers Bureau participant with Bristol Myers Squibb; Fluidigm Corporation; Genmab A/S; Merck & Co., Inc.; Sanofi; and Takeda Pharmaceutical Company Limited.Co-Chair/PlannerVamsidhar Velcheti, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Bristol Myers Squibb; Galvanize Therapeutics, Inc.; GSK; Merck & Co., Inc.; Novocure; TAIHO ONCOLOGY, INC.; and Takeda Pharmaceutical Company Limited.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/KBV865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until February 17, 2025.Simplifying the Complicated: An Algorithmic Guide for Clinical Decision-Making in HR+, HER2- EBC and MBC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerErika Hamilton, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Arcus Biosciences, Inc.; Arvinas, Inc.; AstraZeneca; Daiichi Sankyo, Inc.; Deciphera Pharmaceuticals, Inc.; Ellipses Pharma; F. Hoffmann-La Roche Ltd/Genentech, Inc.; Greenwich LifeSciences, Inc.; iTeos Therapeutics; Janssen Pharmaceuticals, Inc.; Lilly; Loxo Oncology; Mersana Therapeutics; Novartis Pharmaceuticals Corporation; Orum Therapeutics; Pfizer; Relay Therapeutics; Seagen Inc.; and Verascity Science (all paid to institution).Grant/Research Support from AbbVie Inc.; Accutar Biotechnology Inc; Acerta Pharma; ADC Therapeutics SA; Akeso Biopharma Co., Ltd.; Amgen Inc.; Aravive; Artios Pharma; Arvinas, Inc.; AstraZeneca; AtlasMedx, Inc.; BeiGene, Inc.; Black Diamond Therapeutics, Inc.; Bliss Biopharmaceutical (Hangzhou) Co., Ltd.; Boehringer Ingelheim Pharmaceuticals, Inc.; Cascadian Therapeutics; Clovis Oncology; Compugen; Cullinan Oncology, Inc.; Curis, Inc.; CytomX Therapeutics, Inc.; Daiichi Sankyo, Inc.; Dana-Farber Cancer Institute; Dantari; Deciphera Pharmaceuticals, Inc.; Duality Biologics; eFFECTOR Therapeutics, Inc.; Ellipses Pharma; Elucida Oncology, Inc.; EMD Serono, Inc.; F. Hoffmann-La Roche Ltd/Genentech, Inc.; FUJIFILM Pharmaceuticals U.S.A., Inc.; G1 Therapeutics, Inc.; H3 Biomedicine Inc.; Harpoon Therapeutics; HUTCHMED (China) Limited; ImmunoGen, Inc.; Immunomedics, Inc.; Incyte; Infinity Pharmaceuticals, Inc.; InvestisBio; Jacobio Pharmaceuticals Group Co., Ltd.; K-Group Beta, Inc.; Karyopharm; Lilly; Loxo Oncology; Lycera; MabSpace Biosciences Co., Ltd.; MacroGenics, Inc.; MedImmune, LLC; Mersana Therapeutics; Merus; Millennium Pharmaceuticals, Inc.; Molecular Templates, Inc.; Novartis Pharmaceuticals Corporation; Nucana; Olema Oncology; OncoMed Pharmaceuticals, Inc.; Onconova Therapeutics; Oncothyreon; ORIC Pharmaceuticals, Inc.; Orinove Inc.; Pfizer; PharmaMar; Pieris Pharmaceuticals, Inc.; Pionyr Immunotherapeutics; Plexxikon; Radius Health, Inc.; Regeneron Pharmaceuticals Inc.; Relay Therapeutics; Repertoire Immune Medicines; Rgenix Inc.; Seagen Inc.; Sermonix Pharmaceuticals; Shattuck Labs Inc.; Stemcentrx, Inc.; Sutro Biopharma, Inc.; Syndax; Syros Pharmaceuticals, Inc.; Taiho Oncology, Inc.; TapImmune Inc; TESARO, Inc.; Tolmar Pharmaceuticals, Inc.; Torque Therapeutics, Inc.; Treadwell Therapeutics; Verastem, Inc.; Vincerx Pharma; zenithepigenetics; and Zymeworks Inc. (all paid to institution).Faculty/PlannerKomal Jhaveri, MD, FACP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; AstraZeneca; Blueprint Medicines; Bristol Myers Squibb; Daiichi Sankyo, Inc.; Eisai Inc.; F. Hoffmann-La Roche Ltd/Genentech, Inc.; Jounce Therapeutics, Inc.; Lilly/Loxo Oncology; Menarini Group/Stemline Therapeutics; Novartis Pharmaceuticals Corporation; Pfizer; Scorpion Therapeutics; Seattle Genetics, Inc. (Seagen Inc.); Sun Pharma Advanced Research Company; and Taiho Oncology, Inc.Grant/Research Support from ADC Therapeutics SA; AstraZeneca; Blueprint Medicines; Debiopharm; Genentech, Inc.; Gilead Sciences, Inc.; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novita Pharmaceuticals, Inc.; Pfizer; Puma Biotechnology, Inc.; Scorpion Therapeutics; and Zymeworks Inc.Faculty/PlannerProfessor Stephen Johnston, MA, PhD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; Puma Biotechnology, Inc.; and Sanofi.Grant/Research Support from AstraZeneca; F. Hoffmann-La Roche Ltd/Genentech, Inc.; Lilly; Novartis Pharmaceuticals Corporation; Pfizer; and Puma Biotechnology, Inc.Speakers Bureau participant with AstraZeneca; Eisai Inc.; F. Hoffmann-La Roche Ltd/Genentech, Inc.; and Pfizer.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ANR865. CME/MOC/CC/NCPD/CPE/AAPA/IPCE credit will be available until January 16, 2025.Adapting Our Strategies for Decision-Making in Testing and Treatment of RET-Altered Lung and Thyroid Cancers: A Personalized Learning Journey In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerProfessor Benjamin Solomon, MBBS, PhD, FRACP, FAHMS, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen Inc.; AstraZeneca; Bristol Myers Squibb; D3 BIO, INC; F. Hoffmann-La Roche AG; Janssen Pharmaceuticals, Inc.; Lilly; Merck Sharpe & Dohme; Pfizer; and Takeda Pharmaceutical Company.Speakers Bureau participant with AstraZeneca; F. Hoffmann-La Roche AG; and Pfizer.Co-Chair/PlannerLori J. Wirth, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Blueprint Medicines Corporation; Coherus BioSciences; Eisai Co., Ltd.; Ellipses Pharma Ltd; EMD Serono, Inc.; Exelixis, Inc.; Lilly; Merck & Co., Inc.; and Nested Therapeutics.Data Safety Monitoring Board for PDS Biotechnology.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This week on RfRx, Rob Palmer returns to discuss mass psychogenic illness. Have U.S. government employees in Havana and all around the world – even behind the White House gates – been attacked and injured over the past seven years by secret energy-weapons wielded by undiscovered assailants for political reasons? Have thousands of girls in their schools across Iran been poisoned this past year by their Islamic government as retribution for the mass anti-hijab protests? Did a 4-ft tall roller-skating Monkey Man with metal claws and glowing red eyes attack people throughout New Delhi causing injuries and deaths? Believe it or not, there is a connection between these seemingly unrelated headline-grabbing events. This presentation will examine a little recognized and less understood phenomenon that is likely the actual culprit in these and a myriad of similar events that have occurred throughout the world and throughout human history: Mass Psychogenic Illness.Rob Palmer is a retired aerospace engineer. He has been a spacecraft designer, spacecraft tester, computer programmer, and software systems engineer. Rob became a skeptical activist in 2016 upon joining the Guerrilla Skeptics on Wikipedia team, and in 2018 became a columnist for Skeptical Inquirer. To date he has had over 70 articles published by Skeptical Inquirer as well as in other publications, and the Wikipedia articles he's written have garnered over 13 million pageviews.Rob writes about contemporary skeptical issues, and has interviewed individuals as diverse as Neil deGrasse Tyson, Richard Dawkins, Penn Jillette, Ann Druyan (producer and writer for the modern Cosmos series), Dave Warnock (Of Dying Out Loud), Seth Andrews (host of The Thinking Atheist podcast), John de Lancie (Star Trek's Q), and even God - eh, Mr. Deity - himself. Rob is registered with the Center for Inquiry's Speakers Bureau, and has given presentations for various skeptic and humanist groups and conventions, including: We Can Reason, Dragon Con, and three times at CSICon (the annual science and skepticism conference in Las Vegas). He has been interviewed about these subjects on various podcasts and YouTube shows, including The Skeptic Zone, Big Picture Science, Be Rationable, The Phil Ferguson Show, Banachek's Brain, 502 Conversations, Point of Inquiry, The Thinking Atheist, and here for RfRx.All of Rob's skeptical work can be found at: https://linktr.ee/thewellknownskeptic. For RfRx comments, inquiries & topical questions, email us at RfRx@recoveringfromreligion.org. Any time you are struggling with religious doubts or fears you can connect with a trained RfR Helpline agent 24 hours a day, 7 days a week. To chat online go to http://www.recoveringfromreligion.org. To talk over the phone, dial: (844) 368-2848 in the US & Canada If you are in need of professional help, we can offer the Secular Therapy Project to provide options to connect with a professional therapist. All therapists have been thoroughly vetted by our organization and offer only evidence-based and non-religious treatment. Connect with them at http://www.seculartherapy.org. Follow us on Facebook, Twitter, Instagram and Tiktok. Volunteer: http://www.recoveringfromreligion.org/volunteer Donate: https://www.recoveringfromreligion.org/donate --- Send in a voice message: https://podcasters.spotify.com/pod/show/recovering-from-religion/message

In this episode, I am joined by Jennifer Best, Vice President of Marketing at AAE Speakers Bureau. Under her leadership in 2022, AAE launched the inaugural Speaking Industry Benchmark Report, bringing transparency to the speaker booking process between both the meeting organizers who book them and the speakers who delight audiences. Top Takeaways: Public Speaking Benefits: Public speaking is a valuable skill for personal and professional development. It provides a platform to share expertise, educate, and inspire audiences. Starting Small: Begin with local opportunities like community events, schools, or Chamber of Commerce gatherings. Practice and build confidence gradually before aiming for larger conferences. Removing Filler Words, Use Pauses and Gestures: Focus on eliminating filler words like "um" and "so" to enhance the professionalism of your speech. Consider attending workshops or hiring a coach to refine your speaking skills. Integrate pauses strategically, allowing the audience to absorb information and enhancing overall communication. Think of pauses as logical breaks, creating a rhythm in your speech. Utilize gestures authentically to enhance your message. Pay attention to audience cues; adjust your approach based on their reactions. Finding Speaking Opportunities: Explore opportunities with local organizations, non-profits, or industry associations. Utilize a CRM to track and submit proposals for speaking engagements. Niche Topics and Speaker Coaches: Identify a niche topic to stand out in the speaking industry. Consider working with speaker coaches or organizations like the National Speakers Association (NSA). Working with a Speakers Bureau: Understand the role of a Speakers Bureau, which connects speakers with event organizers. Different Bureaus have varying business models, including exclusive representation. Remember, public speaking is a continuous learning journey, and each opportunity contributes to your growth. Whether you're just starting or aiming for larger stages, the key is to be authentic, practice consistently, and embrace the journey of becoming a confident and impactful speaker. Download the latest Speaking Industry Benchmark Report and to be notified in January when the next survey launches, vist https://go.aaespeakers.com/speaking-industry-benchmark-report/ To learn more about AAE Speakers, visit https://www.allamericanspeakers.com. To submit a speaking profile for consideration on AAE's website, go to https://aae.link/add-speaker Articles: 7 Speaking Topic Trends to Watch in 2024: https://www.allamericanspeakers.com/blog/7-speaking-topic-trends-to-watch-in-2024/ Impactful Communication: Jennifer Best Of AAE Speakers Bureau On 5 Essential Techniques for Becoming an Effective Communicator: https://medium.com/authority-magazine/impactful-communication-jennifer-best-of-aae-speakers-bureau-on-5-essential-techniques-for-a76b560a8cf0 Find AAE on the socials @aaespeakers Learn more about Kickbox and get 100 free validation credits: https://kickbox.com Video: https://youtu.be/2ljhkxbpCsY Audio:

Conversation with Michelle Joyce, the founder of an exclusive speaker management company, Michelle Joyce Speakers, and is recognized by Forbes as a Speaker Industry Expert with more than 25 years of speaker management experience representing top keynote speakers in a variety of industries. Episode on Website

In this episode, Tudor discusses the significance of September 11th and introduces her guest, Frank Siller, founder of the Tunnel to Towers Foundation. They discuss the heroism and sacrifices made by first responders and civilians on that day. Frank shares his personal story of his brother Stephen, a firefighter who lost his life on 9/11, and discusses the work of the Tunnel to Towers Foundation in supporting the families of fallen first responders. They emphasize the importance of educating younger generations about 9/11 and never forgetting the sacrifices made. The Tudor Dixon Podcast is part of the Clay Travis & Buck Sexton Podcast Network - new episodes debut every Monday, Wednesday, & Friday. For more information visit TudorDixonPodcast.comFollow Clay & Buck on YouTube: https://www.youtube.com/c/clayandbuckSee omnystudio.com/listener for privacy information.

In this episode, Tudor discusses the significance of September 11th and introduces her guest, Frank Siller, founder of the Tunnel to Towers Foundation. They discuss the heroism and sacrifices made by first responders and civilians on that day. Frank shares his personal story of his brother Stephen, a firefighter who lost his life on 9/11, and discusses the work of the Tunnel to Towers Foundation in supporting the families of fallen first responders. They emphasize the importance of educating younger generations about 9/11 and never forgetting the sacrifices made. The Tudor Dixon Podcast is part of the Clay Travis & Buck Sexton Podcast Network - new episodes debut every Monday, Wednesday, & Friday. For more information visit TudorDixonPodcast.comSee omnystudio.com/listener for privacy information.

In this episode, Tudor discusses the significance of September 11th and introduces her guest, Frank Siller, founder of the Tunnel to Towers Foundation. They discuss the heroism and sacrifices made by first responders and civilians on that day. Frank shares his personal story of his brother Stephen, a firefighter who lost his life on 9/11, and discusses the work of the Tunnel to Towers Foundation in supporting the families of fallen first responders. They emphasize the importance of educating younger generations about 9/11 and never forgetting the sacrifices made. The Tudor Dixon Podcast is part of the Clay Travis & Buck Sexton Podcast Network - new episodes debut every Monday, Wednesday, & Friday. For more information visit TudorDixonPodcast.comSee omnystudio.com/listener for privacy information.

Did you know that the white material on the outside of space shuttles was not metal or glass but actually fabric? Specialized quilts, two inches thick, covered the space shuttles and protected the astronauts from deadly heat and radiation. Jean Wright was one of the eighteen “Sew Sisters” who crafted these thermal blankets, mostly by hand, with incredible precision and skill.  From sending letters to Johnson Space Center as a child with crayon-drawn patch ideas, Jean had always aimed to work for NASA, patiently applying and eagerly awaiting for the job she was meant to have, one that would help secure – in a literal sense- the materials that would protect the vehicles carrying the astronauts to space, and secure her place in NASA history… this is the conversation that you must not miss.  On this very special 200th EPISODE of the Casual Space Podcast, Beth enjoys speaking with Jean Wright, sharing her inspiring stories from her time at NASA as a “Sew Sister.”   Together, Beth and Jean discuss stories from Jean's newly-released book, Sew Sister: The Untold Story of Jean Wright and NASA's Seamstresses.  The book, just like this conversation, unveils both the grandeur of space flight and the intimacy of a needle and thread, and the story of Jean's childhood passion for space and sewing, and her fascinating work for NASA's shuttle program.  Listen as Beth learns the definition of what schnibbles* are.  Note: It's a variant of schnibbles, a far more common term for “scraps,” or “small pieces,” which is heard in parts of the United States that were settled largely by German immigrants. The term comes from German Schnippel, meaning “scraps.” Imagine having the task of cutting the fabric from the 1903 Wright Flyer that went to the Moon with Neil Armstrong, and several shuttle flight- so it could be displayed at the University of Cincinnati .  And guess what kind of fabric the Wright Brother's used for the first flight? A kind of high-end, expensive fabric women would use for their undergarments! “I'm all about fabric!” – Jean Wright, Casual Space Podcast  Jean Wright is a former NASA Aerospace Composite Technician- a NASA seamstress.  Jean worked with the United Space Alliance at the Thermal Protection System Facility at Kennedy Space Center in Florida. One of 18 seamstresses in this critical role, Jean and her co-workers dubbed their group, “The Sew Sisters”, using machines and hand stitching to build, create and repair thermal protection flight hardware and parachutes. Wright worked on the Endeavor, Atlantis and Discovery space shuttle missions. She also worked on test parachutes and aft-skirt blankets for the Orion spacecraft. When she's not sewing, Jean is a photographer for SpaceUpClose; www.spaceupclose.com  Beth's Note: I especially loved “Big Mo,” “Sweet Sue”, and “Lurch” - the names of the sewing machines used by Jean and her team at NASA (some from 1914)!  More about Jean:  Jean says she's retired, but she's ever the most incredible NASA advocate, photographer, speaker and representative.  Jean remains involved with NASA as a Docent for the Shuttle Atlantis exhibit at the Kennedy Space Center. She is a member of NASA's Speakers Bureau, representing the organization at civic, professional, educational and public events. She has been a keynote speaker at the MQX Quilt Festival in 2018, Women's History Month at KSCVC in 2018, Family Day at the Udvar-Hazy National Air & Space Museum in 2016, the International Quilt Festival with Astronaut Karen Nyberg and the Denver Museum of Nature and Science. One of her life's biggest thrills was being asked by Mark Armstrong to cut and prepare for auction, pieces of historic muslin fabric from the Wright Brothers 1903 Flyer that his father, Neil Armstrong, carried to the moon aboard the Apollo 11 Lunar Module. Pre-order Jean's book here: https://www.amazon.com/Sew-Sister-Untold-Wright-Seamstresses/dp/0884489825/ref=sr_1_1?crid=35842DQC0D3T2&keywords=sew+sister+the+untold+story+of+jean+wright&qid=1693428497&sprefix=sew+sister%2Caps%2C103&sr=8-1  Apply for a NASA Moon tree here: https://www.nasa.gov/press-release/nasa-forest-service-to-share-moon-tree-seedlings-promote-stem  And don't forget to send your story to space at www.storiesofspace.com

Warren Villagomez, Director of Public Health Hospital for the Emergency Preparedness Program at the Commonwealth Health Care Corporation, shares the public health planning lessons learned form COVID-19; Hsini Lin, Office Chief for Environmental Epidemiology at the Arizona Department of Health Services, explains the ADHS response to record breaking heat; ASTHO has a new Speakers Bureau that connects event organizers with expert speakers; and sign up for ASTHO's Public Health Weekly email newsletters.   ADHS: Extreme Weather & Public Health ASTHO: Climate and Health ASTHO: Speakers Bureau ASTHO Webpage: Public Health Weekly email newsletters

From humble beginnings, Sue Falcone has lived and is still living the American Dream! As a former Corporate Executive, Professional Speaker, Bestselling Author, Sue is now the Founder and CEO of the unique Remarkable! A Speakers Bureau. Sue has been blessed with great mentors, who taught her to believe in herself and not let her past become her identity. As a mentor herself, she gives back and helps others become the best version of themselves. She shares: “You don't have to compete or compare yourself to anyone or anything, you just have to be IN the competition!” Sue is married to Carmen Falcone, (her CFO), Mom to 4, Grandma to 5, and will soon be a Great-Grandma! With no plans to retire, Sue shares: “Retirement is not in my DNA!” Sue loves living debt free, dancing, working out, and exploring new adventures to expand her company! 

Friday on Political Rewind: Since August of 2001, Soumaya Khalifa has worked through the Islamic Speakers Bureau to educate Georgians on the ins and outs of life as a Muslim woman in America. The panel Soumaya Khalifa, founder and Executive Director, Islamic Speakers Bureau of Atlanta Timestamps 0:00 - Introduction 3:00 - On Soumaya Khalifa's childhood, from Egypt to the U.S.. 9:00 - Khalifa founded the Islamic Speakers Bureau of Atlanta in August of 2001. 20:00 - What it means to be a Muslim in America. 33:00 - Americans frequently ask Muslim women if they're oppressed. 40:00 - On the conflict between Israel and Palestine. 46:00 - On antisemitism and Islamophobia.